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Cytochrome bc1 Complex in Respiration and Photosynthesis 
 
The cytochrome bc1 complex, or ubiquinol-cytochrome c oxidoreductase, which can 
be found in the inner membrane of mitochondria or in cytoplasmic membrane of many 
bacteria, is a central component of the electron transfer pathway for their respiration or 
photosynthesis (1-5).  The complex catalyzes the oxidation of quinol and reduction of 
soluble c-type cytochromes with the generation of a proton gradient and a membrane 
potential. The combination of the proton gradient and the membrane potential is referred 
to as proton motive force (pmf).  The pmf is the driving force for synthesis of ATP by the 
F1F0-ATP synthase in the membrane. 
All the cytochrome bc1 complexes contain four redox centers: two b type hemes (bH 
and bL) in a cytochrome b subunit, one c type heme (c1) in a cytochrome c1 subunit, and a 
high potential [2Fe-2S] cluster in the Rieske iron-sulfur protein.   
In chloroplasts and cyanobacteria, a very similar complex called the cytochrome b6f 
complex, or plastoquinol-plastocyanin oxidoreductase, replaces the cytochrome bc1 
complex for participation in the electron transfer chains of their oxygen-evolving 
 2
photosynthesis.  The cytochrome b6f complex has a smaller cytochrome b subunit 
corresponding to only the N-terminal heme-bearing part of bc1 complex’s cytochrome b 
subunit, while a sequence similar to the C-terminal part is present in a separate subunit 
(6,7).  The cytochrome f is structurally unrelated to cytochrome c1, although the 
cytochrome f is a c-type cytochrome.  Because of the similarity between bc1 and b6f, the 
term “cytochrome bc1 complex” is often used to include the cytochrome b6f complex (3), 
and most features of bc1 complex discussed here should apply to the b6f complex as well. 
The cytochrome bc1 complex does not exist universally in all organisms (3). For 
example, some bacteria like Escherichia coli do not possess a bc1 complex, and they 
complete their respiration by transferring electrons directly from ubiquinol to oxygen via 
an ubiquinol-oxidase, cytochrome bo3.  However, since the cytochrome bc1 complex is a 
central component of the electron-transfer pathway for both mitochondria and 
chloroplast, it is an absolutely necessity for eukaryotic organisms. 
In mitochondria, the cytochrome bc1 complex, usually known as complex III, is a part 
of the respiratory electron-transport chain.  Two products of the citric acid cycle, NADH 
and succinate, are electron donors of the electron-transport chain.  Electrons are passed 
from NADH through complex I (NADH-ubiquinone reductase), or from succinate 
through complex II (succinate-ubiquinone reductase), and then to ubiquinone, complex 
III, cytochrome c, complex IV (cytochrome c oxidase), and to a final electron acceptor—
oxygen.  Protons are translocated across the membrane as electrons pass through these 
complexes (except complex II) to generate the proton motive force as mentioned above.  
In the aerobic respiratory system of bacteria, the bc1 complex plays a similar role as the 
one in mitochondria. 
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In addition to the respiratory system, the bc1 complex is also found in bacterial 
photosynthetic electron transport systems.  In the facultative photosynthetic purple non-
sulfur bacterium Rhodobacter sphaeroides, there is a cyclic photosynthetic pathway with 
the bc1 complex as an obligatory electron transfer complex.  The photosynthetic electron 
transfer is initiated as the light energy is absorbed inside the photosynthetic reaction 
center by the primary donor, P870 (a bacteriochlorophyll), which has an absorption 
maximum at 870 nm.  Light-harvesting complexes surrounding the reaction center help 
absorb the light more effectively over a wide range of wavelengths shorter than 870 nm.  
The light-harvesting complexes are proteins attached with bacteriochlorophyll and 
carotenoid pigments.  Excited by the light energy, the P870 becomes a relatively stronger 
reducing agent (lower redox potential), and is thermodynamically capable of donating an 
electron to the next electron carrier.  The electron is then transferred inside the reaction 
center to a bound quinone at site QB via a second bacteriochlorophyll, a 
bacteriopheophytin, and a bound quinone at site QA.  After accepting two electrons, the 
quinone at the site QB becomes fully reduced as Q2-, and immediately uptakes two 
protons from the cytoplasm (negative side) to produce QH2.  The reduced QH2 can now 
serve as the substrate for the ubiquinol-cytochrome c reductase reaction in the bc1 
complex.   
Same as in the mitochondrial bc1 complex, for every mole of QH2 that is oxidized, 
two moles of cytochrome c2 (cytochrome c equivalent in purple bacteria) are reduced, and 
four moles of proton are translocated across the membrane.  The reduced cytochromes c2 
then carry electrons back to the photosynthetic reaction center and reduce the P870 of the 
reaction center.  Therefore, in this cyclic pathway, there is no exogenous electron donor 
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or a final electron acceptor.  Electrons continuously recycled between the reaction center 
and the bc1 complex with light energy serving as the driving force, resulting protons 
pumped across the membrane to form the proton motive force.   
A more complicated photosynthetic pathway occurs in chloroplast with cytochrome 
b6f complexes instead of cytochrome bc1 complexes.  However, as mentioned above, 
cytochrome b6f complex is very similar to cytochrome bc1 complex structurally and 
functionally.  There are two photosynthetic reaction centers in this pathway, photosystem 
I and photosystem II.  The photosystem II is equivalent to the reaction center in R. 
sphaeroides, but there is no cyclic pathway between photosystem II and cytochrome b6f 
complex as in R. sphaeroides.  In chloroplast, water is the electron donor for the 
photosysthesis, and electrons are released from a water splitting reaction, which is absent 
in the bacterial reaction center.  Plastoquinol (PQ, and equivalent of ubiquinol), which is 
reduced in photosystem II, transfers electrons through the cytochrome b6f complex to 
plastocyanin (PC, an equivalent of cytochrome c).  The reduced PC then transfers its 
electron to photosystem I.  Excited by light energy, photosystem I transfers the electrons 
to NADP+ and produce NADPH via an NADP reductase.  The major difference between 
photosystem I and II is that the redox potential of photosystem I is low enough to reduce 
NADP+.  Therefore, in addition to the generated proton motive force, a strong electron 
donor (NADPH) is produced by this pathway.  An alternative cyclic photosynthetic 
pathway also exists in chloroplasts: the electrons from excited photosystem I can go back 
to cytochrome b6f complex via the plastoquinone.  In this case, more proton motive force 
is generated by the cytochrome b6f complex for ATP synthesis without the need for 




The bc1 complex can basically be considered as a “proton pump” which moves 
protons across the membrane by utilizing the potential energy due to the redox potential 
difference between ubiquinol and cytochrome c.  The simplest arrangement for electron 
transfer should be a linear pathway, in where, the electron transfer components are 
arranged in an ascending order of their redox potentials as shown here: 
QH2   ⎯→  bL  ⎯→  bH ⎯→ ISP ⎯→ c1 ⎯→ c 
The immediate problem of this model is the difficulty in explaining the two-
protons/one-electron stoichiometry of the reaction observed in the bc1 complex (8).  
Among all the electron transfer components within the bc1 complex, only ubiquinol 
serves as a carrier for both protons and electrons. Therefore, for every electron going 
through the complex, only one proton has the chance to be translocated in the linear 
electron transfer model.  
In addition, the linear model is very unlikely to be the electron transfer pathway 
because it can not explain the phenomenon known as “oxidant-induced reduction of 
cytochrome b”.   This phenomenon was observed by Chance (9): addition of a pulse of 
oxygen to slowly respiring mitochondria causes a transient increased reduction of the 
cytochrome b, particularly in the presence of the inhibitor antimycin.  If the linear model 
were true, we would expect to observe increased oxidation of cytochrome c1, ISP, 
cytochrome b and ubiquinol following a sudden increase of oxidation of cytochrome c.  
Therefore, a more complicated model known as the “Q cycle mechanism” (see Fig. 1) 
was first proposed by Mitchell (10) and modified later (8,11,12) to explain the electron 
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transfer, the proton translocation, the 2:1 H+/e- ratio and the “oxidant-induced reduction 
of cytochrome b” in the cytochrome bc1 complex.  Although there are still some different 
opinions (13,14), it is generally accepted that bc1 complexes operate through the “Q cycle 
mechanism”.   
The two key features of the Q cycle mechanism are 1) the presence of two separate 
ubiquinone binding sites: Qo site and Qi site, and 2) the bifurcated reaction at the Qo site 
(8).  In the bifurcated reaction at the Qo site, one of the two electrons from ubiquinol 
oxidation is “recycled” through cytochrome b, and the ubiquinol can be used one more 
time to carry two more protons.  Therefore it takes only two electrons to translocate four 
protons across the membrane.  Although the detailed mechanism of the bifurcation of 
quinol oxidation at the Qo site is still controversial, it is believed that an ubiquinol (QH2) 
at the Qo site is oxidized by ISP and cytochrome bL in either a concerted mechanism (15-
17) or a sequential mechanism (18-20).  In the concerted mechanism, an electron is 
transferred to heme bL as soon as the other electron is transferred to ISP, and therefore no 
semiquinone is generated (see Fig. 1-A).  In the sequential mechanism, the heme bL is 
reduced by an intermediate ubisemiquinone generated at the Qo site after the first electron 
is transferred to ISP (see Fig. 1-B).  However, the presence of such semiquinone has not 
been detected (16,21).   
In both mechanisms, two protons are released into the positive side of the membrane 
when the quinol is oxidized.  The electron, which has been transferred to ISP, is then 
transferred to cytochrome c1 and then to cytochrome c.  The other electron, which is 
transferred to the bL heme, is then moved to the bH heme.  At the Qi site, a ubiquinone 









































FIG. 1.  The Q-cycle with (A) Concerted and (B) Sequential Bifurcated Reaction 
at Qo Site.  Red lines indicate the electron transfer between redox centers.  The black 
bars show the sites, at which inhibits block electron transfer within the complex.   
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).  At this point, the reaction is only half complete, with only one of two electrons from 
ubiquinol being transferred to cytochrome c.   
In the second half of the Q cycle, all steps are repeated: one ubiquinol is oxidized, one 
cytochrome c is reduced, two protons are deposited into the positive side of the 
membrane, and the bH heme is reduced via the bL heme.  At the Qi site, the 
ubisemiquinone, which is generated in the first half of the Q cycle, accepts another 
electron from the bH heme and uptakes two protons from the negative side of the 
membrane to form ubiquinol (QH2) and complete one Q cycle.  The net result of one 
complete Q cycle generates one molecule of oxidized ubiquinone, two molecules of 
reduced cytochrome c, uptake two protons from the negative side of the membrane, and 
deposits four protons  to the positive side of the membrane, 
QH2 + 2 cyt c3+ + 2H+(N-side)   →  Q + 2 cyt c2+ + 4H+(P-side). 
 
Three-Dimensional Crystal Structures of Cytochrome bc1 and b6f Complex 
 
Three-dimensional structures of mitochondrial bc1 complexes from bovine (22,23) 
and chicken (24) were determined by crystallization and x-ray diffraction at about 3 Å 
resolutions by three groups initially, and later the resolutions were improved to 2.3 Å in 
the yeast bc1 (25), and 2.4 Å in the bovine bc1 structure (26).  The structure of the bovine 
mitochondrial bc1 complex is dimeric and pear-shaped.  The height of the complex is 
approximately 155 Å, and its diameter at its widest point in the matrix space is about 130 
Å.  The complex extends 38 Å into the cytoplasmic space, spans the 42 Å inner 
mitochondrial membrane, and projects 75 Å into the matrix space.  The subunits core 1 
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and core 2, along with subunits 6 and 9, lie entirely in the matrix space.  Cytochrome b, 
cytochrome c1, ISP, and subunits 7, 10, and 11 span the membrane, whereas subunit 8 lies 
solely on the intermembrane space. 
Recently, the crystal structures of cytochrome b6f complexes from the cyanobacteria 
(blue-green algae) Mastigocladus laminosus (27) and Chlamydomonas reinhardtti (28) 
were also solved at 3.0 Å and 3.1 Å respectively.  The crystal structure of b6f complex 
shows also a dimer whose core organization is similar to that of bc1 complex (27,28).  
Although cytochromes f and c1 are not homologous, they occupy roughly equivalent 
positions in the two complexes.  However, the domain arrangement outside the core of 
the b6f complex is different from bc1 complex due to the position of those small subunits 
PetF, PetL, PetM and PetN.  Most striking difference between bc1 and b6f is that an 
additional heme, which is located close to the heme bH, is found in the structure of b6f 
complex.   
With 2.3 Å resolution of the structure, many questions about the detailed mechanism 
still remain unanswered, so a structure with better resolution is still needed.  However, 
the current x-ray structure supports the Q-cycle mechanism, but also suggests two 
unexpected features of the complex.  The most dramatic one is the mobile nature of the 
head domain of the ISP during bc1 catalysis.  The second one is that the dimeric structure 
may be essential for proper function of the cytochrome bc1 complex.   
Movement of Head Domain of ISP 
The mobility of the ISP during bc1 catalysis was first suggested by the observation of 
the low electron density of its extramembrane head domain (22).  The mobile hypothesis 
is further supported by observations of the different positions of the [2Fe-2S] cluster in 
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the presence of various Qo site inhibitors (23,24,29).  To study the movement of the ISP 
head domain by using mutagenesis in R. sphaeroides bc1, Tian et al. (30) demonstrated 
that increasing the rigidity of the ISP neck region by a double-proline substitution at Ala-
46 and Ala-48 or a triple-proline substitution at residues 42-44 decreased the activity and 
increased the activation energy.  In a continuous work, Tian et al.(31) constructed 
mutants with cysteines pairs in the ISP neck region; oxidation of the cystines pair to form 
a disulfide bond to restrict the flexibility of the ISP neck region decreases activity, which 
can be restored by reducing the disulfide bond with β-mercaptoethanol.  To further 
establish the essentiality of the movement of the head domain of ISP, R. sphaeroides bc1 
mutant with a pair of cysteines between cytochrome b and the head domain of ISP was 
generated (32); formation of the inter-subunit disulfide bond, which immobilizes the ISP 
head at the b position, is concurrent with the loss of its bc1 activity, and reduction of this 
disulfide bond by β-mercaptoethanol restores the activity.   
The hypothesis of the mobility of the ISP head domain not only provides an 
explanation for the unexpected findings in those crystal structures, but it may also provide 
an explaination for the bifurcated reaction at Qo site.  The bifurcated quinol oxidation at 
the Qo site is the key step in the Q cycle mechanism as mentioned in the previous section.  
The major problem for the obligatory bifurcated reaction is that one of the two electrons 
from quinol has to be transferred to the unfavorable low potential chain (cytochrome bL 
and bH).  It is difficult to explain why both electrons are not moved to the 
thermodynamically favorable high potential chain (ISP and cytochrome c1).  Several 
models are proposed trying to explain how the bifurcated reaction is controlled, such as 
the catalytic switch model (33), the proton-gate affinity change model (15), and the 
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double-occupancy Qo site model (34).  However, the observation of the mobility of the 
ISP head domain provides a new insight into the bifurcation reaction mechanism.  In the 
structure-based model, it is suggested that the reduced ISP head is held in the position 
close to cytochrome b (b-position) until the second electron is transferred to the low 
potential chain triggering the movement of the ISP head to the position close to 
cytochrome c1 (c position) (29,35).  Since the reduced ISP head in the “b-position” is too 
far away from cytochrome c1 to rapidly transfer electron to cytochrome c1, the ISP would 
keep its reduced state and the second electron of the quinol is not able to go to ISP but to 
cytochrome b (36).  Another possible model based on the structure suggests that the 
reoxidized ISP is unable to return to the b-position to be re-reduced, before the second 
electron is transferred to the low potential chain (20).   
The Intertwined Dimeric Structure of Cytochrome bc1 Complex 
Several observations in the crystal structure suggest that the cytochrome bc1 complex 
is functioning as a dimer (22); 1) the distance between two bL hemes in the two 
monomers is short enough  (21 Å) to transfer electrons between them; 2) the extrinsic 
domain of the iron-sulfur protein of one monomer is in a position close to cytochrome b 
and cytochrome c1 of the other monomer; i.e. the trans-membrane helix of an iron-sulfur 
protein is on one monomer while the extrinsic domain is on the other monomer; 3) there 
is an internal cavity in the complex that connects the Qo pocket of one monomer to the Qi 
pocket of the other.   
To confirm that the cytochrome bc1 complex exists as a dimer with intertwining 
Rieske iron-sulfur proteins not only in crystal but also in solution, Xiao et al. (37) 
demonstrated that the cytochrome bc1 complex exists as a dimer with intertwining Rieske 
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ISPs by using a R. sphaeroides bc1 mutant containing two cysteines pairs. One pair was in 
the interface between the head domain of ISP and cytochrome b, and the other was 
between the tail domain of ISP and cytochrome b.  An adduct protein with an apparent 
molecular mass of 128 kDa containing two cytochrome b and two ISP proteins is detected 
on SDS-PAGE as the protein samples were not treated by β-mercaptoethanol, confirming 
that the bc1 complex exists as a dimer with intertwining ISPs.   
Recently, Gutierrez-Cirlos and Trumpower (38) demonstrated that in the yeast bc1 
complex, stigmatellin and methoxyacrylate stilbene inhibit the enzyme activity with a 
stoichiometry of 0.5 per complex.  The results indicate that only one molecule of such an 
inhibitor is sufficient to completely inhibit two molecules of the bc1 complex and suggest 
the essentiality of the dimeric structure for bc1’s function. 
An ongoing experiment in our lab showing that there may be electron transfer 
between two monomer of the complex (unpublished result), also implies the functional 
significance of the dimeric structure of the complex.        
 
Supernumerary Subunits of Cytochrome bc1 Complex 
 
The protein subunits in the cytochrome bc1 complex can be divided into two groups: 
those that contain a redox prosthetic group, called the core subunits, and those that do 
not, called the supernumerary subunits (39).  All cytochrome bc1 complexes contain three 
core subunits: cytochrome b, cytochrome c1 and Rieske ISP, but they vary significantly in 
the supernumerary subunit composition.  For example, the bc1 complex from bovine heart 
mitochondria has eight supernumerary subunits (40); that from yeast (41) has seven; that 
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of R. sphaeroides has one (42), whereas the complexes from Rhodopseudomonas rubrum 
(43), Paracoccus denitrificans (39), and Rhodobacter capsulatus (44) have none.  
Although the functions of supernumerary subunit are not fully understood, the complexes 
containing no supernumerary subunit are less stable and have lower activity than those 
with supernumerary subunits (41).  It has been reported that cytochrome bc1 complexes 
purified from the mitochondria of bovine heart and yeast, and from the chromatophores 
of R. spharoides and R. capsulatus by a single chromatographic procedure have the 
turnover rates of 1152, 219, 128, and 64 s-1, respectively (41).  The increased activity in 
mitochondrial and R. sphaeroides complexes may result from interactions of the core 
subunits with supernumerary subunits.  
Despite the extensive studies of the three redox-group-containing subunits have 
obtained wealth of knowledge, the functions of the supernumerary subunits are largely 
unknown.  Some studies have been conducted on the function of the supernumerary 
subunits, most of them using the mitochondrial cytochrome bc1 complex.  Subunit I and 
II of yeast bc1  are suggested to be essential for maintaining the proper conformation of 
apocytochrome b to aid in the addition of heme (45,46); subunit VI of yeast bc1 is 
involved in manipulating dimer/monomer transition (47,48); subunit VII and VIII of yeast 
bc1 are essential for assembly of the complex (49); subunit IX of yeast bc1 interacts with 
the iron-sulfur protein, cytochrome b and cytochrome c1 (50); subunit I and II of plant or 
bovine bc1 have the mitochondrial-processing peptidase activity (51,52).  However, the 
presence of multiple supernumerary subunits in the mitochondrial cytochrome bc1 
complexes makes their studies complicated.  The cytochrome bc1 complex from R. 
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sphaeroides, with only one supernumerary subunit, is therefore an ideal system to study 
the function of the supernumerary subunits. 
 
Photosynthetic Bacteria Rhodobacter sphaeroides 
 
Rhodobacter sphaeroides is an anoxygenic, non-sulfur, purple facultative 
photosynthetic bacterium.  In contrast to plants and algae, which carry out photosynthesis 
in an aerobic environment and produce oxygen as a product of the water splitting 
reaction, R. sphaeroides carries out photosynthesis in an anaerobic condition, and does 
not produce oxygen.  Actually, the synthesis of some photosynthetic pigments (e.g. 
bacteriochlorophyll) in R. sphaeroides is repressed by oxygen (53).  Its preferred growth 
mode is photoheterotrophic, under anaerobic conditions in light with various organic 
substrates.  Therefore, the ecological niches of R. sphaeroides are anoxic parts of waters 
and sediments, which receive light of sufficient quantity and quality to allow phototrophic 
development (53).  However, R. sphaeroides is not a strict anaerobe.  It is quite tolerant 
of oxygen and grows well under aerobic conditions in the dark.  Under aerobic 
conditions, synthesis of bacteriochlorophyll is repressed, so the culture becomes pink 
colored rather than brownish green as seen in photosynthetic cultures.   
A very important feature and advantage of R. sphaeroides as a material for bc1 
complex study is that the bc1 complex is not essential for its aerobic growth, since the 
electron from quinol can be transferred to oxygen via a quinol oxidase as an alternative 
electron transfer pathway.   Therefore, R. sphaeroides mutants with severely defective bc1 
complexes are still able to survive and grow in large quantities under aerobic conditions.  
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However, for preparation of bc1 complex, the bacteria are grown under “semi-aerobic” 
conditions in order to have intra-cytoplasmic membrane (ICM) developed inside the 
bacteria in the presence of limited oxygen.   
In addition, bacteria are much easier to handle experimentally than animals, plants 
and even unicellular eukaryote like yeast, especially for mutagenesis studies.  Since the 
cytochrome bc1 complex from R. sphaeroides is believed similar in its structure and 
function to the much more complicated complex from mitochondria (4), the mutagenesis 
results from the bacteria can be applied on the mitochondrial complex.  Furthermore, 
efficient molecular engineering procedures for R. sphaeroides are well established, and 
the genes of all its four subunits have been cloned and sequenced (54,55). 
The most important feature that makes the R. sphaeroides an ideal system to study the 
supernumerary subunit of the bc1 complexes is that it has only one supernumerary subunit 
-- subunit IV, in contrast to 8 for bovine bc1 complex, or 7 for yeast bc1 complex.   
 
Previous Studies on Subunit IV of Rhodobacter sphaeroides bc1 Complex 
 
The Rhodobacter sphaeroides cytochrome bc1 complex was purified from several 
laboratories with different procedures, and was found to contain four subunits (41,56-58).  
Subunit IV was found to be an integral part of the complex as follows by using anti-
subunit IV affinity column chromatography (59).  When detergent-solubilized 
chromatophore was passed through an anti-subunit IV affinity column, no QCR activity 
was completely removed in the effluent.  Under the identical conditions, when solubilized 
chromatophore was passed through a preimmune IgG affinity column, only less than 10% 
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of the activity was lost.  When the proteins absorbed to the subunit IV affinity column 
were eluted with low pH buffer and subjected to SDS-PAGE, all the four subunits of the 
complex were detected.  None of these proteins were found in the eluates of the 
preimmune IgG affinity column.  These results clearly indicate that subunit IV is an 
integral part of R. sphaeroides bc1 complex. 
The gene for subunit IV (fbcQ) has been cloned and sequenced (55).  Although 
subunit IV is an integral part of the complex, the fbcQ gene is found (55) at least 3 kb 
away from the fbc operon, which encodes ISP (fbcF), cytochrome b (fbcB) and 
cytochrome c1 (fbcC).  The subunit IV gene is 372 base pairs long and encodes 124 amino 
acid residues.  The molecular mass of subunit IV, deduced from the nucleotide sequence, 
is 14,384 Da.  No homology has been found by comparing its sequence with the 
supernumerary subunits of bc1 complexes from other organisms.  Based on the 
hydropathy analysis, residues 86 to 109 are predicted as a transmembrane helix (55).  The 
C-terminal end of subunit IV has been suggested to be on the periplasmic side (positive 
side) and the N-terminal end on the cytoplasmic side (negative side) (60), and this is 
confirmed in this study. 
To facilitate the study of subunit IV, a fbcQ gene lacking R. sphaeroides strain 
(RS∆IV) was constructed and characterized (61).  There are three characteristic features 
in this RS∆IV strain, on comparison with the wild-type R. sphaeroides: 1) RS∆IV 
requires a period of adaptation (about 48 hours) before the start of photosynthetic growth; 
2) the chemical composition,  spectral properties, and the bc1 activity in chromatophores 
from the adapted RS∆IV is comparable to wild-typed chromatophores. However, the 
apparent Km for Q2H2 for the bc1 reaction in RS∆IV chromatophores is about four times 
 17
higher than the wild-type chromatophores; 3) the bc1 activity in RS∆IV chromatophores 
is more sensitive to detergent treatment than wild-type chromatophores.  These 
observations suggest the structural role and the Q-binding function of subunit IV (61). 
The Q-binding function of subunit IV is supported by photoaffinity labeling using 
azido-Q derivatives.  Analysis of the radioactivity distribution among the subunits of the 
bc1 photoaffinity labeled with radioactive azido-Q derivatives shows both cytochrome b 
and subunit IV to be heavily labeled, and hence can be identified as Q-binding proteins 
(62).  To identify the Q-binding domain in subunit IV, a [3H]-azido-Q-labeled subunit IV 
was isolated and digested by protease V8.  The labeled peptide was then separated by 
HPLC, and identified as amino acid residues 77-124 of subunit IV by sequencing its 
partial N-terminal (55).   
With a similar approach, subunit VII of bovine mitochondrial bc1 complex was also 
identified as the small molecular weight Q-binding protein, in addition to cytochrome b 
(63).  Based on amino acid sequence comparisons, subunit IV of R. sphaeroides bc1 
complex is not homologous with any supernumerary subunits in mitochondrial bc1 
complex, but is functionally homologous to the subunit VII (62,63).  Therefore, the 
subunit IV portion in a proposed 3-D R. sphaeroides bc1 complex model (64) is 
constructed using the coordinates of subunit VII of the mitochondrial bc1 complex’s 
crystal structure.   
However, according to the crystal structure of the bovine bc1 complex, subunit VII is 
too far from the possible Q-binding sites to be a part of either the Qo or the Qi site.  
Although exact location of Qo site is still controversial, it is generally believed to be in 
proximity to the binding positions of the Qo site inhibitors, like myxothiazol or 
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stigmatellin.  If the subunit IV of R. sphaeroides bc1 complex is in the position as 
proposed in the model, the azido-Q binding fragment would be too far from the Q-
binding sites.  Therefore, it is still not clear how the Q-binding feature of subunit IV is 
involved in the functioning of the bc1 complex.  
To study the function of subunit IV, an in vivo gene complementation approach is 
used.  We constructed a pRKD plasmid containing wild-type or mutated subunit IV gene 
(fbcQ), and introduced the complement into RS∆IV.  The plasmid encoded subunit IV 
and the chromosome encoded cytochrome b, cytochrome c1, and ISP would assemble in 
vivo.  This in vivo reconstituted (or gene complemented) strain has the same features as 
the wild-type strain (61).  Using site-directed mutagenesis on the subunit IV gene 
followed by in vivo reconstitution, we identified some essential amino acid residues 
involved in Q-binding or structural functions of subunit IV.  Amino acid residues 6-11 
are found to be essential for the structural function of subunit IV, Trp79 is found to be 
essential for the function of both structure and Q-binding, while Thr77, Tyr81, residues 2-
5, and residues 113-124 are found to be not essential (65).  However, when the deletion 
was extended more than 10 residues, the resulting mutant strain contained no subunit IV.  
Since the mRNA of the mutant subunit IV can be detected with Northern blots, the 
absence of subunit IV is likely due to the instability of the mutated subunits IV within the 
R. sphaeroides (65). 
To solve the difficulty presented by mutagenesis studies by the in vivo reconstitution 
approach, an in vitro reconstitution approach was developed (66).  The expression 
plasmid, pGEX/IV, is constructed by in frame ligation of subunit IV gene with the 
glutathione-S-transferase (GST) gene on the pGEX-2T plasmid.  Under the control of the 
 19
tac promoter, the expression is inducible by isopropylthiogalactoside (IPTG).  The 
expressed GST-subunit IV fusion protein can be purified from cell extract with 
glutathione-agarose gel.  The purified recombinant subunit IV protein is then obtained by 
thrombin digestion of the fusion protein to remove GST.  Reconstitution of the 3-subunits 
cytochrome bc1 complex in vitro with this recombinant subunit IV has activity and 
property similar to those of wild-type complex.  This is an indication that the recombinant 
subunit IV is functionally active and can be properly assembled into the active 
cytochrome bc1 complex (66).  By using site-directed mutagenesis coupled with in vitro 
reconstitution, it is possible to study the interaction of subunit IV and the 3-subunit core 
complex. 
 
Electron Leakage and Superoxide Generation in the bc1 Complex 
 
It has been reported that about 1-2% of oxygen consumption during normal 
respiration is not involved with oxidative phosphorylation, but rather with the formation 
of superoxide (67).    Complex I and Complex III (bc1 complex) were identified as two 
segments responsible for much of the superoxide generated in mitochondria (68-71).  In 
the bc1 complex, ubisemiquinone radical (68) and reduced cytochrome b566 (or bL) (69) 
are suggested as the autoxidizable factors causing superoxide production during the 
ubiquinol-cytochrome c reductase turnover.   
Superoxide is a free radical capable of causing oxidative damage to the 
mitochondrion and cellular proteins, lipid, and nucleic acids. Also acute exposure to 
superoxide and other reactive oxygen species can inactivate the iron-sulfur clusters of 
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complex I, II, and III, resulting in shutdown of the mitochondrial respiratory chain (72).  
Superoxide and other reactive oxygen species generated in mitochondrion are reported to 
be related to diseases associated with respiratory chain or superoxide dismutases (SOD) 
abnormal functioning (72,73).  However, under normal circumstances, the superoxide 
generated from mitochondria does little damage, since it is efficiently removed by SOD.  
In addition, generation of superoxide during respiration has two physiological purposes: 
regulation of membrane potential and maintenance of body temperature (35). 
For bc1 complex, the generation of superoxide could be under control if the 
ubisemiquinone or reduced cytochrome bL are well protected from contact with oxygen.  
It is possible that the supernumerary subunits of bc1 complex may provide such 
protection.  Most studies of the superoxide generated by bc1 complex are focused on its 
medical significance or on the enzymatic mechanism of the bc1 complex.  No one has 
reported the relationship between the superoxide generation by bc1 complex and the 
supernumerary subunits of the complex.  In this study, the involvement of subunit IV on 
reducing the electron leakage and superoxide generation is discussed.  
     
The Purpose and Strategy of Study 
 
The purpose of this study is to understand the role of the supernumerary subunit, 
subunit IV, in the cytochrome bc1 complex from a photosynthetic bacterium R. 
sphaeroides.  The specific aims are: 1) to identify amino acid residues of subunit IV 
involved in interaction with the 3-subunit core complex; 2) to investigate the effect of 
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subunit IV on the thermo-stability of the cytochrome bc1 complex; 3) to investigate the 
role of the subunit IV in preventing electron leakage from the bc1 complex.  
Various subunit IV mutants were generated and characterized to identify the regions 
and individual amino acid residues of subunit IV required for interaction with the core 
complex to restore activity.  The effect of the transmembrane helix region of subunit IV 
on its assembly into the complex was investigated by testing the association between 
subunit IV mutants and histidine-tagged 3-subunit bc1 complex, which binds strongly to 
the Ni-NTA gel.  The effect of ISP on the incorporation of subunit IV to the complex was 
also examined.  The effect of subunit IV on the stability of the complex was investigated 
by differential scanning calorimetry (DSC).  Mutations on certain critical amino acid 
residues of subunit IV were tested for their effect on activity restoration, incorporation 
with the core complex, and stability of the complex to understand their roles in subunit 
IV’s function.  To investigate the possibility that subunit IV is able to prevent electron 
leakage, the pre-steady state kinetic of quinol oxidation by bc1 complex, and superoxide 
generation were studied by using stopped-flow kinetic analyzer coupled with the 
chemiluminescent reagent 2-methyl-6-(-p-methoxyphenyl)-3,7-ddihydroimidazo[1,2-











MATERIALS AND METHODS 
 
Growth of Bacteria 
 
Rhodobacter sphaeroides  
Plasmid bearing Rs∆IV cells (61) were grown photosynthetically at 30°C in an 
enriched Sistrom medium containing 5 mM glutamate and 0.2% casamino acids.  Cells 
were harvested with centrifugation at 3,500 x g for 30 minutes, when the turbidity 
(OD600nm) of the cell culture reached 2.0.  The harvested cells were then washed with 20 
mM Tris-succinate buffer, pH 7.5, and stored at -20°C.  About 5 – 6 grams of cells are 
routinely obtained from 1 liter of culture.   
Antibiotics were added at the following concentrations: tetracycline, 10–15 mg/liter; 
kanamycin sulfate, 20 mg/liter; and trimethoprim, 25 mg/liter. 
Escherichia coli 
For general purpose, E. coli cells were grown aerobically at 37°C in LB medium.  For 
the rescue of single-stranded DNA used in site-directed mutagenesis, E. coli cells were 
grown in TYP broth, which contained 16 g Bacto-trypton, 16 g Bacto-yeast extract, 5 g 
NaCl, and 2.5 g K2HPO4.   
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For over-expression of GST-subunit IV fusion protein, KS-1000 E. coli cells 
containing pGEX-2T/IV were grown with the following procedures.  A 2.5 ml of 
overnight culture was inoculated into a 250 ml LB medium containing ampicillin in a 
1000 ml flask.  The culture was incubated at 37°C with shaking until the OD600nm reached 
0.6-0.8.  The culture was then incubated in ice to stop the cell growth.  Cells were 
collected with centrifugation and resuspended in 10 ml of fresh LB medium before being 
inoculated into a fermentor with 6 liters of LB medium containing 2% glucose.  The 
fermentor was kept at 23°C with stirring and aeration.  Several drops of antifoam solution 
(Sigma A5551) were added to avoid the formation of foam.  When the OD600nm of the 
culture reached 0.8 to 1.0 (usually 12-14 hours from inoculation), IPTG was added to 
final concentration of 0.2 mM.  The cells were harvested by centrifugation at 3,500 x g 
for 30 minutes after 6 hours of IPTG induction, washed with 100 ml of PBS buffer, and 
stored at -20°C. 
Antibiotics, when needed, were added at the following concentrations: ampicillin, 
100–125 mg/liter; tetracycline, 10–15 mg/liter; kanamycin sulfate, 30–50 mg/liter; and 
trimethoprim, 85–100 mg/liter. 
 
Construction of Expression Plasmid and Site-Directed Mutagenesis 
 
Construction of R. sphaeroides Strains Expressing the His6–Tagged 4-Subunit and 3-
Subunit Cytochrome bc1 Complexes 
The expression plasmid for His-tagged four-subunit wild-type cytochrome bc1 
complex (pRKDfbcFBCHQ) was constructed previously in our laboratory (30).  A 1.2-kb 
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XbaI-HindIII fragment containing the fbcC and fbcQ genes from pRKDfbcFBCQ, 
containing fbcF, fbcB, fbcC, and fbcQ, was ligated into a modified pSELECT-1 vector in 
which the unique Acc65I (5’...G▼GTACC...3’) site was eliminated.  The resulting 
pSELfbcCQ was used as template for site-directed mutagenesis to introduce an Acc65I 
recognition site right before the stop codon of the fbcC gene with Altered Sites in Vitro 
Mutagenesis System.  Two complementary oligonucleotides with 6His tag coding 
sequence and the Acc65I overhang (5’...GTAC...3’) attached at the 5’...ends (5’-GT ACG 
GGC CAT CAC CAC CAC CAT CAC TAA...3’ and 3’...C CCG GTA GTG GTG GTG 
GTA GTG ATT CAT G...5’) were synthesized, annealed together by heating up to 70 °C 
and cooling slowly to room temperature, and ligated into the Acc65I site of pSELfbcCQ 
to generate pSELfbcCHQ.  The 6-histidine insertion was confirmed by DNA sequencing. 
A 1.2-kb XbaI-HindIII fragment containing fbcCHQ from pSELfbcCHQ was ligated into 
XbaI and HindIII sites to obtain pRKDfbcFBCHQ.     
The expression plasmid for the subunit IV-deficient, three-subunit core complex 
(pRKDfbcFBCH) was generated by digestion of the pRKDfbcFBCHQ plasmid with 
BamHI and HindIII to remove the fbcQ gene, filling in with Klenow and annealing the 
ends.   
The resulting pRKDfbcFBCHQ and pRKDfbcFBCH were transformed into E. coli 
S17, and then mobilized into R. sphaeroides BC17 and Rs∆IV, respectively by parental 
conjugation to generate pRKDfbcFBCHQ/BC17 and pRKDfbcFBCH/RS∆IV.  R. 
sphaeroides BC17 mutant has its entire fbc operon deleted from the chromosome (54);  R. 
sphaeroides Rs∆IV has its fbcQ gene deleted from the chromosome. 
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Construction of an E. coli strain Expressing the Subunit IV  
Recombinant subunit IV is produced by E. coli Ks1000 cells carrying the pGEX/RsIV 
expression plasmid. Plasmid pGEX/RsIV was constructed previously in our laboratory by 
in-frame ligating subunit IV gene (fbcQ) with the GST gene in the pGEX2TH plasmid 
(66).  In order to be able to in-frame ligate the fbcQ with the GST gene on the expression 
vector pGEX-2TH, a BamHI recognition sequence (5’...G▼GATCC...3’) was created by 
site-directed mutagenesis immediately up-stream from the start codon (ATG) of subunit 
IV on the plasmid pSelect/RSIVBB, The resulting plasmid, pSelect/RSIVBBB was digested 
with BamHI to produce a 505-base pair fragment containing fbcQ.  This BamHI fragment 
was ligated into pGEX-2TH to generate pGEX/RSIV.  The plasmid was then transformed 
into E. coli KS1000, which is Prc protease deletion strain (74), to decrease the protease 
digestion of recombinant subunit IV.  Colonies producing recombinant subunit IV were 
identified by immunological screening with antibodies against subunit IV. 
Generation of E. coli Strains Producing Subunit IV Mutants with the Altered Site 
Mutagenesis System from Promega 
Mutations on subunit IV gene were generated by using the single-strand pSelect/IV as 
a template, and a mutagenic oligonucleotide and an ampicillin repair oligonucleotide as 
DNA synthesis primers.  The single-stranded template was prepared by infecting INVαF’ 
E. coli cells containing plasmid pSelect/IV with R408 helper phage.  The plasmid then 
enters the f1 replication mode and the resulting single-strand DNA was exported into the 
growth medium.  The single-stranded DNA was then purified by PEG precipitation and 
phenol/chloroform extraction. 
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The mutagenic oligonucleotides, which were complementary to the single-strand 
template with the desired mutagenic mismatch located in the center, were synthesized 
(listed in Table I).  Before annealing with the template, the mutagenic oligonucleotide 
was 5’-phosphorylated with T4 kinase to increase linkage between the mutagenic 
oligonucleotide and the ampicillin repair oligonucleotide, thereby increasing the chances 
of successful mutation.   
The ampicillin repair oligonucleotide and the mutagenic oligonucleotide were 
annealed to the single-stranded template by heating the annealing mixture to 70° and then 
slowly cooling it down.  Following the annealing, the mutant strand was synthesized and 
ligated by T4 DNA polymerase and T4 DNA ligase at 37°C for 90 minutes.  The resulting 
heteroduplex DNA is then transformed into the repair minus E. coli strain BMH 71-18 
mut S.  Plasmid DNA was then isolated from the cells, which were grown overnight in 
the presence of ampicillin, and transformed into the JM109 strain.  Mutants were 
confirmed by direct sequencing of the plasmid. 
The resulting plasmid was digested with BamHI to produce a 505-bp fragment 
containing mutated fbcQ gene.  This BamHI fragment was then ligated into the BamHI 
site of pGEX-2TH.  Orientation of the gene on the plasmid was confirmed by examining 
the product size of the EcoR I + Sac I digestion.  The plasmid with the correct insert 
orientation would produce a 392 bp fragment instead of a 272 bp fragment.  
Site-directed Mutagenesis on Subunit IV with Polymerase Chain Reaction (PCR) 
PCR amplification was used to generate N-terminal truncated subunit IV mutants.  
Template and oligonucleotide primers used in the mutagenesis are listed in Table I.  The 
forward primer contained the sequence prior to the fbcQ gene on the template and the 
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Table I. MUTATIONS OF SUBUNIT IV 
Mutants Mutagenesis methodsa Template Primers 
    
C-Terminal Truncation 
IV(1-40) AS pSelect/IV CGCCTGGTGCAGAAATCGTGAGAGCTCCTCAACb 
IV(1-76) AS pSelect/IV GCCAGCGCGATTTCGAGTGAGTCTGGAAATATC 
IV(1-85) AS pSelect/IV CGCTACCGCCTCTGAGGCTTCGCCTCG 
IV(1-109) AS pSelect/IV GGCAACTTCGGCGGCTGATCGGACGCCGGCAAC 
    
N-Terminal Truncation 




















    
Alanine Scanning 




















T77A QC pGEX/IV f:CCAGCGCGATTTCGAGGCTGTCTGGAAATATCG 
r:CGATATTTCCAGACAGCCTCGAAATCGCGCTGG 
V78A QC pGEX/IV f:CGCGATTTCGAGACTGCCTGGAAATATCGCTAC 
r:GTAGCGATATTTCCAGGCAGTCTCGAAATCGCG 
continued on next page 
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TABLE I  continued 
W79A QC pGEX/IV f:GATTTCGAGACTGTCGCGAAATATCGCTACCGCCTC 
r:GAGGCGGTAGCGATATTTCGCGACAGTCTCGAAATC 
K80A AS pSelect/IV TTCGAGACTGTCTGGGCATATCGCTACCGCCT 
Y81A QC pGEX/IV f:GAGACTGTCTGGAAAGCTCGCTACCGCCTCGG 
r:CCGAGGCGGTAGCGAGCTTTCCAGACAGTCTC 
R82A QC pGEX/IV f:CTGTCTGGAAATATGCCTACCGCCTCGGCGG 
r:CCGCCGAGGCGGTAGGCATATTTCCAGACAG 
Y83A AS pSelect/IV GAAATATCGCGCCCGCCTCGG 
R84A AS pSelect/IV ATATCGCTACGCCCTCGGCGGCTT 
L85A QC pGEX/IV f:GAAATATCGCTACCGCGCCGGCGGCTTCGCCTCG 
r:CGAGGCGAAGCCGCCGGCGCGGTAGCGATATTTC 












Other Mutations   
W79F QC pGEX/IV f:GATTTCGAGACTGTCTTCAAATATCGCTACCGCCTCG 
r:CGAGGCGGTAGCGATATTTGAAGACAGTCTCGAAATC 
W79Y QC pGEX/IV f:GATTTCGAGACTGTCTACAAATATCGCTACCGCCTCG 
r:CGAGGCGGTAGCGATATTTGTAGACAGTCTCGAAATC 
Y81T QC pGEX/IV f:GAGACTGTCTGGAAAACTCGCTACCGCCTCGG 
r:CCGAGGCGGTAGCGAGTTTTCCAGACAGTCTC 
Y81F QC pGEX/IV f:GAGACTGTCTGGAAATTTCGCTACCGCCTCGGC 
r:GCCGAGGCGGTAGCGAAATTTCCAGACAGTCTC 
R82E AS pSelect/IV GTCTGGAAATATGAGTACCGCCTCGGCGGCT 
R82K AS pSelect/IV GTCTGGAAATATAAGTACCGCCTCGGCGGCT 
Y83T QC pGEX/IV f:CTGGAAATATCGCACCCGCCTCGGCGGC 
r:GCCGCCGAGGCGGGTGCGATATTTCCAG 
Y83F QC pGEX/IV f:CTGGAAATATCGCTTCCGCCTCGGCGGC 
r:GCCGCCGAGGCGGAAGCGATATTTCCAG 
R84E QC pGEX/IV f:GTCTGGAAATATCGCTACGAGCTCGGCGGCTTCGCCTCG 
r:CGAGGCGAAGCCGCCGAGCTCGTAGCGATATTTCCAGAC 
R84K QC pGEX/IV f:GTCTGGAAATATCGCTACAAGCTCGGCGGCTTCGCCTCG 
r:CGAGGCGAAGCCGCCGAGCTTGTAGCGATATTTCCAGAC 
a. AS, Alter Site Mutagenesis System; PCR, Polymerase Chain Reaction; QC, QuickChange 
Mutagenesis System 
b. All primers are listed from 5’ end to 3’ end. 




sequence in the middle of the gene, therefore looped out part of the N-terminal sequence 
as desired.  The reverse primer was complementary to the sequence following the fbcQ 
gene on the template.  Consequently, the PCR product of this pair of primers with the 
fbcQ gene as template would be a double-strand DNA fragment containing fbcQ gene but 
without a certain part of its N-terminal sequence.  To facilitate clone of the PCR product 
into the expression vector, the forward primer included a BamH I site prior to the fbcQ 
gene, and the reverse primer included a Hind III site following the fbcQ sequence.   
PCR amplification was performed in a MiniCyclerTM from M. J. Research.  The 
thermal cycle was set-up as follows: step 1, 94 °C for 1 min; step 2, 92 °C for 40 sec for 
denaturation; step 3, 60 °C for 40 sec for annealing; and step 4, 75 °C for 90 sec for 
extension.  A total of 30 cycles were performed with a final extension step of 5 min.  The 
annealing time for the PCR amplification of the subunit IV(77–109) fragment was set for 
70 s.   PCR products were confirmed by size on agarose gel electrophoresis and cloned 
into the pCR cloning vector pCR2.1 from Invitrogen to generate pCR/IVm plasmids. The 
BamH I-Hind III fragments from pCR/IVm plasmids were ligated into pGEX-2TH vectors 
to generate pGEX/IVm plasmids.  These pGEX/IVm plasmids were individually 
transformed into E. coli KS1000.  Mutations were confirmed by the size of the resulting 
GST-RSIVm fusion protein and the purified mutant subunit IV. 
Site-Directed Mutagenesis on Subunit IV with QuickChange Mutagenesis System from 
Stratagene 
For mutagenesis on subunit IV with the QuickChange system, the expression vector 
pGEX /IV was used as a template and two synthetic oligonucleotides containing the 
desired mutation were used as primers. All template and primers are listed in Table I.  
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The mutagenic oligonucleotide primers of exact complementation are supposed to anneal 
to the opposite strand of template and be extended during a thermal cycle with Pfu DNA 
polymerase. Therefore, a double strand mutant plasmid would be generated.  Similar to 
regular PCR, the thermal cycle was set-up in a MiniCyclerTM from M. J. Research as 
follows:  step 1, 98 °C for 30 sec for initiation; step 2, 98 °C for 30 sec for denaturation; 
step 3, decreasing temperature slowly (1 °C every 8sec) to 55 °C; step 4, 55 °C for 1 min 
for annealing; and step 5, 72 °C for 12 min for extension.  Step 2 to 5 were repeated 18 
times.  Following the thermal cycle, the product was treated with restriction enzyme Dpn 
I.  This digestion was used to select mutation-containing synthesized DNA, because DNA 
isolated from most of E. coli strains are dam methylated at adenine residues in the 
sequence 5’…GmATC…3’ and therefore susceptible to Dpn I digestion, while the in vitro 
synthesized DNA is not. The Dpn I treated product was then transformed into XL1-Blue 
competent cells.  Plasmid purified from a single XL1-Blue colony was sequenced to 




Purification of Histidine-Tagged 3-Subunit Core Complex and 4-Subunit Wild-Type 
Complex 
Frozen R. sphaeroides cells harboring pRKDfbcFBCHQ or pRKDfbcFBCH were 
suspended in 20 mM Tris-succinate, pH 7.5 (3 ml/g of cells), and passed twice through 
French press with at least 16,000 psi (1,000 psig with 1” diameter piston) to break open 
the cells.  Protease inhibitor phenylmethylsulfinyl fluorid (PMSF), which routinely 
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prepared as 0.5 M in dimethyl sulfoxide (DMSO), was added to the cell suspension to a 
final concentration of 1 mM before passing through the French press, and was added to 
same concentration two more times after each passage through the French press.  The 
broken cells were centrifuged at 40,000 xg (19,000 rpm with JA-20 rotor) for 20 minutes 
to remove unbroken cells and cell debris.   The supernatant was then subjected to 
centrifugation at 220,000 x g (49,000 rpm with 50.2 Ti rotor) for 90 min to separate the 
chromatophore fraction from the soluble protein fraction.  The ppt obtained was washed 
with 50 mM Tris-Cl, pH 7.5 containing 1 mM PMSF, and centrifuged at 220,000 x g for 
90 min to recover the chromatophores in ppt.  The resulting chromatophores were 
suspended in 50 mM Tris-Cl, pH 7.5 containing 1mM PMSF and 20% glycerol (final 
volume about 1ml for 1 g of cells), and stored at -80°C, until use. 
To purify the His-tagged cytochrome bc1 complex, the frozen chromatophore 
suspensions were thawed and adjusted to a cytochrome b concentration of 18 µM with 50 
mM Tris-Cl, pH 7.5 containing 1 mM PMSF and 20% glycerol.   Dodecylmaltoside (DM) 
solution (10%, w/v) was added to the chromatophore suspension to 0.66 mg/nmol of 
cytochrome b, and the mixture was stirred at 4 °C for 30 minutes.  NaCl solution (4M) 
was added to a final concentration of 100 mM, and the suspension was stirred for another 
30 minutes at 4°C.  This mixture was centrifuged at 220,000 x g (49,000 rpm with 50.2 
Ti rotor) for 90 minutes.  The supernatant was collected and passed through a Ni-NTA 
agarose column (about 1 ml bed volume for every 100 nmol of cyt. b in the 
chromatophore suspension), equilibrated with 50 mM Tris-Cl, pH 7.5 containing 100 mM 
NaCl and 0.01% DM.  The column, absorbed with bc1 complexes, was then washed with 
20 column volumes of the equilibrating buffer.  The pure cytochrome bc1 complex was 
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eluted with the equilibrating buffer containing 180 mM histidine, and concentrated to a 
final concentration of 300 µM cytochrome b or higher by using a Centriprep concentrator 
with a 30 kDa cut-off.  For the experiment to test the association between 3-subunit bc1 
complex and subunit IV, the purified bc1 complex was dialyzed against 50 mM Tris-Cl, 
pH 7.5 containing 100 mM NaCl and 0.01% DM to remove histidine.  The purified 
complex was stored at -80°C in the presence of 20% glycerol. 
Purification of Recombinant Subunit IV 
Frozen KS-1000 E. coli cells (30-35 g for a typical batch) carrying the pGEX/RsIV 
plasmid were thawed and suspended in 100 ml of PBS (12 mM Na/K phosphate, pH 7.3 
containing 140 mM NaCl and 2.7 mM KCl) and broken by passing through French press 
twice with at least 16,000 psi.  PMSF (0.5 M in DMSO) was added to the cell suspension 
to a final concentration of 1mM, and added two more times after each French press 
passing.  Triton X-100 was added to the broken cell suspension to a final concentration of 
1%.  The suspension was then incubated at 0 °C with stirring for 30 minutes and 
centrifuged at 40,000 x g (19,000 rpm with JA-20 rotor) for 20 min. The supernatant was 
collected and mixed with 30 ml of 50% glutathione-agarose gel slurry equilibrated with 
PBS. The mixture was gently shaken for 30 min at room temperature, and packed into a 
column (2.5 x 15 cm).  After washing with 500 ml of PBS, the GST/subunit IV fusion 
protein was eluted from the column with 60 ml of 10 mM glutathione in 50 mM Tris-Cl, 
pH 8.0, and concentrated to a protein concentration of 10-15 mg/ml using Centriprep-10.  
The fusion protein was treated with thrombin (Sigma T-6884, 2 NIH unit/mg of fusion 
protein) at room temperature for 12 hours to release subunit IV from GST.  After dialysis 
against PBS to remove glutathione from buffer, the thrombin-digested sample was first 
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treated with glutathione-agarose beads to partially remove the released GST and then 
subjected to a gel filtration with a Superdex-200 FPLC column equilibrated with 50mM 
Tris-Cl, pH7.5 containing 100 mM NaCl to completely remove GST and thrombin. 
 
Determination of Protein Concentration 
 
Lowry Method (75) 
The protein sample was diluted to a concentration of 0.1-0.5 mg/ml.  To 0.2 ml of the 
diluted protein sample, 1 ml of copper-alkali solution was added.  The copper-alkali 
solution contained 0.01% of copper sulphate (CuSO4⋅5H2O), 0.02% of sodium potassium 
tartrate, 0.1 M of sodium hydroxide and 2% of sodium carbonate.  After mixing and 
incubating for 10 min, 0.05 ml of Folin-Ciocalteau’s phenol reagent (Sigma F-9252) was 
added.  The absorbance at 500 nm was read after 30 min incubation.  BSA was used as a 
standard to estimate the protein concentration of the sample.   
Bradford Method (76) 
The protein sample was diluted to about 2-10 µg/ml.  To 0.8 ml of a protein sample, 
0.2 ml of Bio-Rad Protein Assay dye reagent (Bio-Rad #500-0006) was added.  The 
reagent contained 0.01% Coomassie Brilliant Blue G-250 in 5% ethanol and 8.5 % 
phosphoric acid.  After incubation for at least 5 min, the absorbance at 595 nm was read.  
BSA was used as the standard. 
Absorbance at 280 nm 
  The protein concentration of purified wild-type subunit IV was estimated by 
measuring absorbance at 280 nm, using a millimolar extinction coefficient of 32.0 cm-1.  
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This extinction coefficient was calculated according to the number of tryptophan (Trp) 
residues and of tyrosine (Tyr) residues in the wild-type subunit IV sequence (5 Trp and 3 
Tyr) by the following equation: 
ε280 [mM-1cm-1] = 5.50 × nTrp + 1.49 × nTyr           (77) 
For Subunit IV mutants whose composition of tryptophan and tyrosine has been altered, 
their extinction coefficients are calculated accordingly. 
 
Determination of Cytochrome Content 
 
The content of cytochrome b was determined from the sodium-dithionite-reduced-
minus-potassium-ferric-cyanide spectrum using the extinction coefficient of 28.5 cm-
1mM-1 for wavelength pair 560 and 576 mm (78).  The content of cytochrome c1 was 
determined from the sodium-ascorbate-reduced-minus-potassium-ferric-cyanide spectrum 
using the extinction coefficient of 17.5 cm-1mM-1 for wavelength pair 552 and 537 mm 
(79). 
   
Enzymatic Activity Assay 
 
The cytochrome bc1 complex was diluted with 50 mM Tris-Cl, pH 7.5 containing 100 
mM NaCl and 0.01% DM to a final concentration of cytochrome b of 3 µM.  Appropriate 
amount (3-10 µl) of this diluted bc1 complex was added to an assay mixture (1 ml) 
containing 100 mM sodium/potassium phosphate, pH 7.4 containing 0.3 mM EDTA, 100 
µM cytochrome c (from horse heart, Sigma C-2506), and 25 µM Q0C10BrH2.  Ubiquinol-
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cytochrome c reductase (QCR) activity of R. sphaeroides bc1 complex was determined at 
room temperature (about 23°C) by measuring the reduction of cytochrome c by following 
the increase in absorbance at 550 nm and using a mM extinction coefficient of 18.5 cm-1.  
Non-enzymatic reduction of cytochrome c, determined under the same conditions in the 
absence of enzyme, was subtracted.  To measure bc1 activity in chromatophores, 30 µM 
potassium cyanide was added to the assay mixture to inhibit the cytochrome c oxidase 
activity. 
 
SDS-Polyacrylamide Gel Electrophoresis (PAGE) 
 
SDS-PAGE for examining proteins smaller than 10 KDa was performed according to 
Schagger and von Jagow (80).  Otherwise, SDS-PAGE was performed according to 
Laemmli (81). 
 
Differential Scanning Calorimetry (DSC) 
 
For DSC analysis, the bc1 sample was diluted in phosphate buffer (Na/K Pi 100 mM, 
pH 7.4) instead of Tris buffer to avoid the large pH change during the heating.  Prior to 
being loaded into the “sample cell” of a CSC Nano-DSC II, 0.6 ml of protein sample was 
degassed for 5 min to remove dissolved air, which may interfere with the DSC data 
during the heating process.  The same volume of buffer was loaded into the “reference 
cell” of the instrument, after being degassed.  During the scanning, both the sample and 
the buffer were heated from 10 °C to 90 °C, cooled back to 10 °C and heated again to 90 
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°C.  The cells were equilibrated at 10 °C and 90 °C for 10 min before heating and 
cooling.  The difference of power input between the “sample cell” and the “reference 
cell” was recorded in µW, with 1 data point taken every 10 seconds, as heating and 
cooling of the cells were done in a steady rate of 1°C per minute.  The second heating 
scan was used as the baseline.  Melting temperature (Tm) and enthalpy change (∆H) of the 
sample were calculated by using the “CpCalc” program. 
 
Pre-steady State Kinetics Measurements 
 
Pre-steady state kinetics measurements were performed by stopped-flow spectroscopy 
using the Applied Photophysics SX.18MV stopped-flow spectrometer with a Photodiode 
Array accessory.  Each reaction was started by mixing 50 µl of 6.0 µM bc1 complex in 
100 mM Na/K phosphate, pH 7.4 containing 0.01% DM, 0.1% BSA, 1mM KCN, and 
1mM NaN3 with an equal volume of 50 µM Q0C10BrH2 in 5 mM NaH2PO4, 0.01% DM, 
0.1% BSA, 1mM KCN, 1mM NaN3, at 23°C.  A spectrum from 600 nm to 500 nm, with 
a resolution of 2.17 nm was recorded every 1.25 msec.  The dead time of the instrument 
was about 2 msec.  The reduction of cytochrome b and c1 was monitored with the 
absorption change in the wavelength pair 562-542 nm and 551-532 nm, respectively.  The 
potassium ferric cyanide treated and sodium dithionite treated bc1 complexes were used 






Superoxide Anion Radical Generation Measurement 
 
To measure the superoxide radical generation during the electron transfer from quinol 
to the b or c1 heme in the bc1 complex, the complex and ubiquinol were mixed by the 
stopped-flow mixer in the same manner as described in the preceding section, except 0.4 
µM MCLA was added to the quinol containing syringe.  The generation of superoxide 
was monitored by detecting the chemiluminescence of the MCLA-superoxide adduct 
(82,83) with an emission photomultiplier on the stopped-flow spectrometer. The 
chemiluminescence was detected and recorded every 0.5 msec for 2 sec.  Superoxide 
produced by the xanthine oxidase reaction with hypoxanthine as substrate was used as a 










LOCALIZTION OF REGIONS ESSENTIAL FOR INTERACTION WITH THE 




Purified 3-subunit core complex has a fraction of bc1 activity of the 4-subunit wild-
type complex.  Addition of recombinant, wild-type subunit IV to the 3-subunit core 
complex restores the bc1 activity to the same level as that of wild-type complex, indicates 
that the recombinant subunit IV is properly assembled into the complex.  Thus, we can 
use the reconstitution active recombinant subunit IV to study its interaction in the bc1 
complex by site-directed mutagenesis coupled with in vitro reconstitution.  In this chapter 
we report generation and characterization of subunit IV mutants which identify the 
regions of subunit IV required for interaction with the core complex to restore bc1 
activity.  The topological arrangement of subunit IV in the chromatophore membrane is 
determined by monospecific polyclonal antibodies for various segments of subunit IV.  
The effect of the transmembrane helix region of subunit IV on its assembly into the bc1 
complex is investigated.  The effect of Rieske iron-sulfur protein on the incorporation of 
subunit IV to the bc1 complex is also examined.  
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Results and Discussion 
 
Requirement of Residues 86-109 for Reconstitutive Activity of Subunit IV 
To localize the regions required for reconstitutive activity, recombinant subunit IVs 
with progressive deletion of amino acid residues from the C-terminus were generated and 
characterized.  These are: IV(1-109, ), IV(1-85), IV(1-76), and IV(1-40), with deletions of 
15, 39, 48, and 84 amino acid residues from the C-terminus of subunit IV, respectively.   
These four C-terminal truncated subunit IV mutants are produced in E. coli as GST 
fusion proteins using constructed expression vectors, pGEX/IV(1-109), pGEX(IV(1-85), 
pGEX/IV(1-76), and pGEX/IV(1-40), respectively.  These expression vectors were 
constructed by in-frame ligation of the subunit IV gene having the stop codon genetically 
engineered at positions 328-, 256-, 229-, and 121-bp down stream from the start codon, 
respectively, into the GST gene in the pGEX-2TH vector.  The yield and purity of these 
four recombinant GST-mutant IV fusion proteins are comparable to that of GST-wild-
type IV fusion protein (see Fig. 2A).  Purified recombinant subunit IV mutants, IV(1-40), 
IV(1-76), IV(1-85), and IV(1-109) (see Fig. 2B) are obtained from their respective fusion 
proteins by thrombin cleavage and gel filtration.  
Table II shows reconstitutive activities of the C-terminal truncated subunit IV 
mutants, with and without fused GST.  Addition of purified recombinant IV(1-109) to the 
three-subunit complex restores the cytochrome bc1 complex activity to the same level as 
that of the recombinant wild-type IV, suggesting that 15 amino acid residues (residues 
110-124) on the C-terminus of subunit IV are not essential.  This result is consistent with 















FIG 2. SDS-PAGE of the C-terminal truncated subunit IVs, with and without 
fused GST.   A. Fused with GST on 12% Tris-Glycine gel: lane 1, protein standard: 
phosphorylase b (97,400), bovine serum albumin (66,200), ovalbumin (45,000), 
carbonic anhydrase (31,000), soybean trypsin inhibitor (21,500), and lysozyme 
(14,400); lane 2, GST-IV(1-40); lane3, GST-IV(1-76); lane 4, GST-IV(1-85); lane 5, 
GST-IV(1-109); lane 6, GST-wild-type IV(1-124).  The SDS-PAGE system of 
Laemmli (81) was used.  (B) Purified mutant proteins on 16% Tris-Tricine gel: lane 1, 
protein standard: triosephosphate isomerase (26,625), myoglobin (16,950), α-
lactalbumin (14, 437), aprotinin (6,512), insulin b chain, oxidized (3,496), bacitracin 
(1,423); lane 2, IV(1-40); lane 3, IV(1-76); lane 4, IV (1-85); lane 5, IV (1-109); lane 






Table II.  Reconstitutive Activities of the C-Terminal Truncated Subunit IV Mutants. 
 
Reconstitutive Activity, % 
Preparations Fused GST Free 
Wild type 100  100  
IV(1-109) 99  97  
IV(1-85) 8  0  
IV(1-76) 6  0  
IV(1-40) 0  0  

















Table III.  Reconstitutive Activities of N-terminal truncated mutants of IV(1-109). 
 
Reconstitutive Activity, % 
Preparations Fused GST Free 
Wild type 100  100  
IV(1-109) 99  97  
IV(21-109 95  90  
IV(41-109) 98  96  
IV(54-109) 53  n.d.  
IV(77-109) 53  50  
IV(86-109) 4  3  
IV(86-124) 0  0  
The 100% reconstitutive activity is that restored by recombinant wild-type IV or GST-wild type IV. 
n.d, not be determined due to protein aggregation.  
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of subunit IV does not impair the cytochrome bc1 complex activity (61).  While the IV(1-
109) mutant possesses full reconstitutive activity, the IV(1-85) mutant shows no 
reconstitutive activity, indicating that residues 86-109 are essential.  As expected, mutants 
IV(1-76) and IV(1-40) have no reconstitutive activity because the essential residues 86-
109 are missing.  
As shown in Table II, when these four C-terminal truncated subunit IVs fused with 
GST are added to the three-subunit core complex, the percent activity restoration is the 
same as when non-fusion proteins are added, indicating that the N-terminal portion of 
subunit IV may not be essential for its interaction with the three-subunit core complex.  
Subunit IV Requires Its Transmembrane Helix Region for Assembly into the Cytochrome 
bc1 Complex  
Since residues 86-109 are essential for reconstitutive activity of subunit IV, it is 
important to elucidate the role this fragment plays during reconstitution.  In the proposed 
structure of subunit IV (41), constructed based on hydropathy plots of the deduced amino 
acid sequence and possible α- and β- sheets, residues 86-109 comprise the only 
transmembrane helix.  Therefore, the role of this fragment may be to provide membrane 
anchoring of subunit IV in the bc1 complex.  To confirm this speculation a His6-tagged 
core complex was generated, characterized and used for incorporation studies of the C-
terminal truncated subunit IVs, using Ni-NTA columns.  The three-subunit core complex 
with a 6-histidine tagged at the C-terminus of cytochrome c1 is constructed by deleting 
the subunit IV gene (fbcQ) from pRKDfbcFBCHQ.  The resulting plasmid PRKDfbcFBCH 
is immobilized into an R. sphaeroides strain lacking the subunit IV gene (RS∆IV).  The 
His6-tagged core complex is purified from dodecylmaltoside solubilized chromatophores 
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in one step on a Ni-NTA column (66).  The purity, activity, and cytochrome content of 
this His6-tagged three-subunit core complex are similar to those of the un-tagged 
complex.  However, the yield of purified His6-tagged core complex is twice that from un-
tagged bc1 preparations and is obtained in 1/5 the time.  When recombinant subunit IV is 
added to this His6-tagged core complex, the extent of activity restoration is the same as 
that with the un-tagged complex, indicating that this His-tagged core complex is suitable 
for incorporation studies of recombinant subunit IV mutants.  
When the His6-tagged core complex is mixed with mutants IV(1-109), IV(1-85), 
IV(1-76), and IV(1-40), respectively, for 1 hr at 0 oC before being applied to Ni-NTA 
columns, the IV(1-109) is associated with the core complex in the same manner as the 
wild-type IV (see Fig. 3, lanes 2 &3), while IV(1-85) (see Fig. 3, lane 4), IV(1-76) and 
IV(1-40) (data not shown) do not associate with the His6-tagged core complex.  This 
result indicates that subunit IV requires its transmembrane helix region for assembly into 
the bc1 complex.  The lack of reconstitutive activity for mutants IV(1-85), IV(1-76) and 
IV(1-40) (see Table II) results from an inability of these mutants to bind to the complex 
because the transmembrane helix region is missing.  The Rieske iron sulfur protein (ISP) 
was also reported to require its transmembrane helix for assembly into the bc1 complex 
(84).  
The Iron-Sulfur Protein Is Not Involved In the Association of Subunit IV with the bc1 
Complex 
The finding that a purified two-subunit complex (cytochromes b  and c1), lacking both 
subunit IV and ISP, is obtained from chromatophores of mutants with altered ISP necks, 











FIG 3.  SDS-PAGE of proteins eluted from Ni-NTA gels.  3.0 µl aliquots of 
His6-tagged three-subunit core complex, 30 mg/ml, containing 320 µM cytochrome 
b,  were added 100 µl of buffer containing 42 µg of IV (1-124) (lane 2), 39 µg of 
IV(1-109) (lane 3), 33 µg of IV(1-85) (lane 4), 24 µg of IV(41-109) (lane 5), and 
none (lane 6).  The mixtures were incubated at 4 ˚C for one hour and mixed with 0.2 
ml of Ni-NTA gel.  After washing the gel with 1 ml of B100 buffer (50 mM TrisCl 
pH 7.5, 0.01% dodecylmaltoside, 100 mM NaCl) twice, the proteins absorbed on 
the gel were eluted with 50 µl of B100 buffer containing 200 mM histidine, and 






investigate the effect of ISP on incorporation of subunit IV.  The His6-tagged, three-
subunit and two-subunit complexes were incubated with recombinant subunit IV at 
dodecylmaltoside concentrations ranging from 0.01% to 1%, for 1 hr at ˚C, and passed 
through Ni-NTA columns.  The amount of subunit IV recovered in the column eluate of 
the three-subunit and the two-subunit complexes were the same (data not shown), 
indicating that incorporation of subunit IV into the bc1 complex does need the presence of 
ISP.  The simultaneous loss of ISP and subunit IV when the ISP neck is altered suggests 
that interaction between subunit IV and cytochrome b and/or c1 involves ISP indirectly; 
alteration of the ISP neck may induce some changes on b or c1 and thus decrease their 
affinity to subunit IV.  
Identification of Residues 77-86 and 41-53 as Essential for Reconstitutive Activity of 
Subunit IV 
Although the transmembrane helix region (residues 86-109) is required for subunit IV 
to be assembled into the bc1 complex, addition of this fragment, generated by deletion of 
85 amino acid residues from the N-terminus of IV(1-109) to yield IV(86-109), to the 
three-subunit core complex restores little bc1 activity (see Table III).  This suggests that 
the reconstitutive activity of subunit IV involves interaction with the core subunits after 
incorporation into the complex through the transmembrane helix.  Since the IV(1-109) 
mutant has the same reconstitutive activity as that of recombinant wild-type IV, the 
interacting region must be in residues 1-85, as residues 86-109 are the transmembrane 
helix.  Therefore, to identify the regions interacting with the core subunits, four other N-
terminal truncated mutants of IV(1-109):  IV(21-109), IV(41-109), IV(54-109), and 
IV(77-109), with progressive deletion of 20, 40, 53, and 76 amino acid residues were 
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generated and characterized.  The purity and yield of IV(21-109), IV(41-109), and IV(77-
109), isolated free (see Fig. 4B) or as the GST fusion proteins (see Fig. 4A), are 
comparable to those of recombinant wild-type IV or the IV(1-109) mutant.  The IV(54-
109), once cleaved from GST by thrombin digestion, becomes insoluble.  Including 
0.02% dodecylmaltoside in the fusion protein preparation during thrombin digestion did 
not prevent the released mutant protein from aggregation.  The yield of recombinant 
IV(86-109) is low, about 10% of that obtained with recombinant wild-type IV, because a 
severe protease digestion occurred during the fusion protein preparation.   
Table III compares maximum reconstitutive activities of mutants IV(86-109), IV(86-
124), IV(77-109), IV(54-109), IV(41-109), and IV(21-109), with and without fused GST.  
Although the IV(86-109) mutant, which contains only the transmembrane helix, has little 
reconstitutive activity, the IV(77-109) mutant has 50% of the reconstitutive activity of the 
wild-type IV, indicating that residues 77-85 are involved in activation of the core 
complex.  The increase in reconstitutive activity of the IV(77-109) mutant is not due to an 
increase in its hydrophilicity upon addition of residues 77-85 because the IV(86-124) 
mutant, with 15 down stream amino acid residues added to the transmembrane helix, has 
little or no reconstitutive activity.  This result further confirms that residues 110-124 are 
not required.    
The GST-IV(54-109) fusion protein has essentially the same reconstitutive activity as 
that of the GST-IV(77-109) fusion protein or IV(77-109) mutant, indicating that residues 
54-76 are not essential.  The IV(41-109) mutant has the same reconstitutive activity as the 
recombinant wild-type IV (a 2-fold increase of reconstitutive activity of the GST-IV(54-





















FIG.4.SDS-PAGE of the N-terminal truncated mutants of IV(1–109) with and 
without fused GST. A, fused with GST: lane 1, protein standard; lane 2, GST-
IV(86–124); lane 3, GST-IV(86–109); lane 4, GST-IV(77–109); lane 5, GST-IV(54–
109); lane 6, GST-IV(41–109); lane 7, GST-IV(21–109). B, purified mutant proteins: 
lane 1, protein standard; lane 2, IV(77–109); lane 3, IV(54–109); lane 4, IV(41–109); 
lane 5, IV(21–109). The SDS-PAGE systems and protein standards used were the 
same as described in the legend to Fig. 2. 
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with residues 21-40 added to the IV(41-109) mutant, has the same reconstitutive activity 
as that of wild-type IV, indicating that residues 21-40 are not involved in interacting with 
the core complex.  Thus, two regions of subunit IV, residues 41-53 and 77-85, in addition 
to the transmembrane helix (residues 86-109), are essential for optimal interaction with 
the core complex to restore the bc1 complex activity.   
Localization of Interacting Regions of Subunit IV in the Proposed Structure of R. 
sphaeroides Cytochrome bc1 Complex 
Although the structural model for subunit IV (41) was constructed on hydropathy 
plots of its amino acid sequence, using the program of Kyte and Dolittle (85), and on 
predicted α and β helices, the sideness of the membrane is unknown. Lack of knowledge 
of the topological arrangement of subunit IV in the chromatophore membrane makes it 
difficult to localize the putative interacting regions of subunit IV in the bc1 complex 
without the three-dimensional structure of this bacterial complex, which is not yet 
available. Therefore, the sideness of the membrane in the proposed structural model of 
subunit IV was determined using Fab’-horseradish peroxidase conjugates, prepared from 
antibodies against synthetic peptides corresponding to residues 59–73 (the near N-
terminal peptide) and 110–124 (the C-terminal peptide), in sealed (inside-out) and broken 
chromatophores. 
When sealed and broken chromatophore preparations are treated with Fab’ fragment-
horseradish peroxidase conjugates prepared from anti-C-terminal peptide antibodies, 
peroxidase activity is observed only with the broken chromatophores (Fig. 5), indicating 
that the C-terminal end is exposed on the periplasmic side of the chromatophore 
membrane. When sealed and broken chromatophore preparations are treated with Fab` 
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fragment-horseradish peroxidase conjugates prepared from anti-near N-terminal peptide 
antibodies, peroxidase activity is observed with both sealed and broken chromatophores 
(see Fig. 5), indicating that the N-terminal end is exposed on the cytoplasmic side of the 
chromatophore membrane.  Thus, the first two putative interacting domains of subunit IV 
are on the cytoplasmic side of the chromatophore membrane (see Fig. 6).  To further 
understand the subunit IV interaction with the core subunits, a three-dimensional 
structural model for the R. sphaeroides bc1 complex (see Fig. 7) was constructed. The 
three core subunits are modeled using coordinates of beef heart mitochondrial 
cytochrome b, cytochrome c1, and ISP, respectively, because of the sequence homology.  
Subunit IV is built in using the coordinates of subunit VII, which is functionally 
analogous.  In this model, the three putative interaction domains of subunit IV are in close 
proximity to cytochrome b: the first domain is close to the DE loop, the second to helix 
G, and the third to helices H and G. Ionic interactions between Asp 46  (IV) or Asp 52 
(IV), and Arg 231 (b) and between Glu 47 (IV) and Lys 234 (b) can be seen in the first 
interaction domain (Fig. 8, lower left).  The interaction between the second domain of 
subunit IV and helix G of cytochrome b is through hydrogen bonding (Fig. 8, lower 
right). The backbone oxygens of Phe 428 and Ile 365 of cytochrome b form hydrogen 
bonds with Trp 79 , and Arg 84 of subunit IV, respectively.  In addition, two oxygen 
atoms in the carboxylic acid group of Glu 425 of cytochrome b also form hydrogen bonds 
with Lys 80 of subunit IV. The interaction between the third domain and helices G and H 
of cytochrome b is hydrophobic (Fig. 8, upper right). Confirmation of these interactions 
will have to wait until the three-dimensional structure of this bacterial cytochrome bc1 














FIG.6.Localization of interacting regions in the proposed structural model of 








FIG.5. Binding of Fab` fragment-horseradish peroxidase conjugates prepared 
from antibodies against a near N-terminal peptide (residues 59–73) (gray bars) 
and the C-terminal peptide (residues 110–124) (black bars) with sealed (A) and 
broken (B) chromatophores. The indicated amounts of sealed and broken 
chromatophores were mixed with 10 mili units of Fab`-horseradish peroxidase 
conjugates prepared from anti-near N- or anti-C-terminal peptide antibodies in 50 mM 
sodium phosphate, pH 7.4, containing 0.25 M sucrose and incubated at 4 °C for 3 h. 
Mixtures were centrifuged at 30,000 x g for 15 min and the precipitate suspended in 
50 mM sodium phosphate, pH 7.4, containing 0.25 M sucrose. This procedure was 
repeated for 3 more times before aliquots were assayed for horseradish peroxidase 
activity. Preimmune Fab`-horseradish peroxidase conjugate treated with sealed and 
broken chromatophores in an identical manner was used as control. The activities 













FIG. 6. Localization of interacting regions of subunit IV in the proposed 





























FIG.7. Localization of interacting regions of subunit IV in the proposed 














FIG.8. The docking between sub-unit IV and cytochrome b in R. sphaeroides 
bc1 complex. Cytochrome b is indicated in blue and subunit IV is in red. 
The boxed areas (interaction regions) shown in the figure at the upper left are 








IDENTIFICATION OF AMINO ACID RESIDUES OF SUBUNIT IV INVOLVED IN 





In the previous chapter, three regions of subunit IV; residues 41-53 (region I), 77-85 
(region II), and 86-109 (region III) were found to be essential for the reconstitutive 
activity of subunit IV.  Region III, which comprises the only transmembrane helix in the 
proposed model of subunit IV, is required for the incorporation of subunit IV into the bc1 
complex.  However, addition of region III alone to the three-subunit core complex cannot 
restore the bc1 activity, suggesting that reconstitutive activity of subunit IV requires 
interaction of regions I and II with the core complex after it is incorporated into the 
complex.   
In continuing our efforts to understand the interaction between subunit IV and the 
core complex, we generated and characterized subunit IV mutants with alanine 
substitution at regions I and II.  This was done to establish that the loss of reconstitutive 
activity in subunit IV mutants lacking region II, but not region I, is due to the essentiality 
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of the region, and not to improper protein assembly or folding resulting from the deletion.  
After the essentiality of region II is established, we used alanine scan in this region to 
identify amino acid residues involved in reconstitutive activity of subunit IV.  We also 
generated and characterized subunit IV mutants to establish the functional groups of the 
identified essential residues in region II.   
 
Results and Discussion 
 
Tyrosine 81, Arginine 82, Tyrosine 83 and Arginine 84 Are Essential for the 
Reconstitutive Activity of Subunit IV 
Previous studies indicate that three regions of subunit IV: residues 41-53 (region I), 
77-85 (region II) and 86-109 (region III) are involved in interaction with the 3-subunit 
core complex to restore the bc1 activity.  Region III, which comprises the only 
transmembrane helix of subunit IV is shown to be required for subunit IV to incorporate 
into the complex, but the functions of Region I and II are not yet defined.  However, a 
possibility exists that the loss of reconstitutive activity observed for the IV(54-109) and 
IV(86-109) might result from improper protein assembly or folding due to the large 
deletion rather than missing some specific amino acid residues on those two fragments.  
Therefore, to ensure that residues 41-53 and 77-85 of subunit IV are essential, 
recombinant subunit IV mutants with alanine substitution in these two regions were 
generated and tested for their ability to restore the bc1 activity of the 3-subunit core 
complex.  As shown in Table IV, when the IV(41-53)A mutant was mixed with the 3-
subunit core complex, the bc1  activity was restored to the same level as was done by the 
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wild-type subunit IV, indicating that residues 41-53 are not essential.  The IV(77-85)A 
mutant restored only 15% of the activity restored by wild-type subunit IV.  These results 
confirm that residues 76-85, but not residues 41-53, of subunit IV are essential for 
interaction with the core subunits of the bc1 complex.      
After confirming that residues 77-85 are required for reconstitutive activity of subunit 
IV, our next logic step would be to identify the essential amino acid residues in this 
region.  To achieve this purpose, the recombinant subunit IV mutants with single alanine 
substitution at each residue from 77 to 85 were generated and determined for their 
reconstitutive activities.  As shown in Table IV, when tyrosine 81, arginine 82, tyrosine 
83 and arginine 84 are replaced individually with alanine, the subunit IV mutants have 
only about 80% of the reconstitutive activity of the wild-type subunit IV, while the 
subunit IV mutants T77A, W79A, and K80A have more than 95% of the reconstitutive 
activity, and V78A and L85A have more than 100% of the reconstitutive activity.  These 
results indicate that Y81, R82, Y83, and R84 are essential for the reconstitutive activity 
of subunit IV.  The subunit IV mutant (77-85)A, as mentioned above, has only 15% of the 
reconstitutive activity suggesting that the effect of the multiple mutations in this region 
are combination of the mutants with single alanine mutation.  The subunit IV mutant (81-
84)A, in which all the four essential residues were changed to alanine, lost 76% of the 
reconstitutive activity supporting the above suggestion.  
Effect of the Mutations on the Interaction of Subunit IV with the Core Complex  
To further investigate the interaction of the residues 77-85 of subunit IV with the core 
complex and ability to restore the bc1 activity, the binding affinities of subunit IV mutants 
T77A, V78A, W79A, K80A, Y81A, R82A, Y83A, and R84A to the core complex, 
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Wild-type IV 100 Y81T 63 
(41-53)A 106 Y81F 83 
(77-85)A 15   
(81-84)A 24 R82E 56 
T77A 95 R82K 95 
V78A 105   
W79A 98 Y83T 58 
K80A 97 Y83F 87 
Y81A 83   
R82A 77 R84E 55 
Y83A 80 R84K 100 
R84A 76   
L85A 101   
*180 µl aliquots of histidine-tagged three subunit core complex, 3.3 µM cytochrome b, in TrisCl 
buffer, pH 7,5 containing 100 mM NaCl and 0.01% dodecylmaltoside, were mixed with 20 µl of 
purified recombinant wild-type and mutant subunit IV’s, 60 µM, in 50 mM TrisCl buffer, pH 7.5, 
containing 100 mM NaCl, 0.01% dodecylmaltoside and 20% glycerol.  The mixtures were incubated 
at 4°C for 1 h before the cytochrome bc1 complex was assayed.  The 100% reconstitutive activity 
represents the extent of activity increase as the 3-subunit complex reconstituted with wild-type 
subunit IV.  Every result is average of at least three repetitions; the deviation between repetitions is 
typically less than 5%. 
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relative to that of wild type subunit IV, were determined.  The availability of a His6-
tagged 3-subunit core complex in our laboratory enables us to use Ni-NTA for this study.  
The wild-type and mutant subunit IV’s were mixed with the His6-tagged core complex, at 
a molar ratio of subunit IV/cytochrome c1 of 2.  The reconstituted mixture contains 13.5 
µM of the 3-subunit His6-tagged complex and 27 µM of subunit IV. Two hundred µl 
aliquot of each of the reconstituted complexes was applied to three columns containing 
150 µl of Ni-NTA gel equilibrated with 50 mM Tris-Cl, pH 7.5, containing 100 mM 
NaCl and 0.01% dodecylmaltoside.  The columns were then washed with 20 column 
volumes of the buffer containing 0.01%, 0.02%, and 0.05% dodecylmaltoside 
respectively in 50 mM Tris-Cl buffer, pH 7.5, and 100 mM NaCl.  The proteins absorbed 
to the columns were eluted with 50 mM TrisCl, pH 8.0, containing 180 mM histidine, 
100 mM NaCl, and 0.01% dodecylmaltoside, and subjected to SDS-PAGE.  The amount 
of subunit IV remaining in the column effluent was quantified by its intensity on gel with 
Coomassie blue staining.     
Fig. 9-A, B, and C show SDS-PAGE patterns of proteins eluted from Ni-NTA 
columns after washing with buffer containing 0.01%, 0.02% and 0.05% dodecylmaltoside 
respectively.  The amounts of subunit IV (both wild-type and mutants) recovered in the 
Ni-NTA column effluents decrease as the concentrations of dodecylmaltoside used in the 
washing step was increased.  On the other hand, little change in the amounts of the core 
subunits (cyt. b, cyt. c1, and ISP) was observed.  In Fig.9-A, after the 0.01% DM wash, all 
subunit IV mutants recovered in the column effluent were comparable to the wild-type 















FIG. 9. SDS-PAGE of reconstituted bc1 eluted from Ni-NTA columns after 
washing with various concentration of dodecylmaltoside.  One hundred fifty-µl 
aliquots of His6-tagged three-subunit core complex, 18 µM cytochrome c1, were 
added to 50-µl of TNDG buffer (50 mM Tris-Cl, pH 7.5, containing 100 mM NaCl, 
0.01% dodecylmaltoside, and 20% glycerol) containing no subunit IV (lane N), 5.4 
nmol of wild-type subunit IV (lane W), mutant subunit IV T77A (lane 77), V78A 
(lane 78), W79A (lane 79), K80A (lane 80), Y81A (lane 81), R82A (lane 82), 
Y83A (lane 83), R84A (lane 84) or L85A (lane 85).  After 1 hour incubation at 4 
°C, the mixture of each reconstituting sample was applied to columns containing 
150 µl of Ni-NTA gel equilibrated with TND (50 mM TrisCl buffer, pH 7.5, 
containing 100 mM NaCl and 0.01% dodecylmaltoside).  Columns were washed 
with 3 ml of 50 mM TrisCl buffer, pH 7.5, containing 100 mM NaCl and (A) 
0.01%, (B) 0.02%, or (C) 0.05% dodecylmaltoside, respectively.  After washing, the 
proteins absorbed on the columns were eluted with 150 µl of TND containing 180 
mM histidine and subjected to SDS-PAGE.  The protein standard: bovine serum 
albumin (66,200), ovalbumin (45,000), carbonic anhydrase (31,000), soybean 
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concentration in the washing buffer is increased to 0.02% and 0.05%, the amount of 
subunit IV mutants IV(W79A), IV(R82A), and IV(L85A) recovered in the column 
effluents decrease significantly upon comparison with wild-type subunit IV (Fig. 9-B and 
C).  Therefore, subunit IV mutants IV(W79A), IV(R82A), IV(Y83A), IV(R84A), and 
IV(L85A) apparently show weaker binding to the core complex, as compared to wild-type 
subunit IV.  Among these weakly bound subunit IV mutants, IV(R82A), IV(Y83A) and 
IV(R84A) were also found to have lower reconstitutive activity as mentioned in the 
previous section.  Therefore, it is likely that the decrease in the reconstitutive activity of 
the IV(R82A), IV(Y83A), and IV(R84A) results from the decrease in binding affinity of 
these subunit IV mutants.   
However, with up to 0.05% DM wash, the amount of the mutant IV(Y81A) remains 
the same as that of the wild-type subunit IV, as shown in Fig. 9.  Therefore, the decrease 
in reconstitutive activity observed for the IV(Y81A) mutant seems to be unrelated to the 
decrease of the binding affinity of this mutant IV to the core complex.  The reason for low 
reconstitutive activity of the mutant IV(Y81A) is still not clear. 
In addition, the amount of IV(W79A) and IV(L85A) associated with the core complex 
also decreased after the reconstituted mixture in the Ni-NTA column was washed with 
0.05% DM.  However, in the reconstitutive activity test (Table IV), these two mutants 
showed no significant activity loss.  Apparently, the tryptophan 79 and leucine 85 are 
required for the binding of subunit IV to the core complex, but the conditions in the 
reconstitutive activity test were not stringent enough to show reconstitutive activity loss 
of the subunit IV mutants W79A and L85.  
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Effect of the Subunit IV on the Thermostability of Cytochrome bc1 Complex  
Fig. 10 shows DSC thermograms of the 3-subunit core complex, reconstituted 4-
subunit complex.  The DSC thermogram of wild-type 4-subunit complex (not shown 
here) is comparable to that of the reconstituted complex.  All of them show symmetrical 
endothermal transition peaks.  The 4-subunit complex denatures at 46.4 °C, which was 
significantly higher than the melting temperature (Tm) of the 3-subunit complex at 42.1 
°C.  With a Tm higher by 4.3 °C, the complex with subunit IV is more stable than the 
complex without subunit IV.  In addition to the melting temperature, the values of the 
total enthalpy change (∆H), which represent the energy needed to complete the 
denaturation and are calculated from the area under the endothermal peak, are 
significantly different.  While the reconstituted 4-subunit bc1 complex has ∆H of 97 
kcal/mol, the ∆H of the 3-subunit bc1 complex is only 55 kcal/ mol.  The energy 
difference between these two ∆H’s suggests that there could be several bonds created 
either inside the core complex, or between the core complex and subunit IV, as the 
subunit IV is incorporated into the position.  Therefore, the DSC analysis of a 
reconstituted bc1 complex is a good indicator for how well a mutant subunit IV assembled 
itself into the complex. 
DSC Studies of bc1 Complexes Reconstituted with Subunit IV Mutants  
All the subunit IV mutants were reconstituted with the 3-subunit core complex and 
subjected to DSC analysis under the same condition mentioned in the previous section.  
The thermal parameter results of these analyses are shown in Table V.  DSC data of the 
complex with IV(41-53)A was comparable to that of the complex with wild-type subunit 



































FIG. 10.  DSC thermograms of reconstituted bc1 complexes.  The solid line is the 
DSC thermogram of histidine tagged 3-subunit cytochrome bc1 complex with 
concentration of cytochrome b equaling to 30 µM in 83 mM phosphate, 8 mM 
TrisCl pH 7.4/ 17 mM NaCl/ 0.002% DM/ 3.3% glycerol.  The dashed line is the 
DSC thermogram of the same sample in the same condition but with 40 µM of 







Table V. DSC thermal parameters of bc1 complexes with wild-typed or mutant subunit 
IV 
Protein Tm, °C ∆H, kcal/mol Protein Tm, °C ∆H, kcal/mol 
∆IV 42.1 55 ∆IV+IV(W79Y) 46.2 99 
wt 46.4 99 ∆IV+IV(W79F) 45.5 89 
∆IV+IV wt 46.4 97    
∆IV+IV(41-53) 46.3 96 ∆IV+IV(Y81T) 43.8 84 
∆IV+IV(77-85) 43.0 61 ∆IV+IV(Y81F) 45.4 95 
∆IV+IV(81-84) 42.3 68    
∆IV+IV(T77A) 46.5 99 ∆IV+IV(R82E) 43.9 84 
∆IV+IV(V78A) 45.5 90 ∆IV+IV(R82K) 45.3 91 
∆IV+IV(W79A) 44.4 82    
∆IV+IV(K80A) 45.3 95 ∆IV+IV(Y83T) 43.8 88 
∆IV+IV(Y81A) 44.8 93 ∆IV+IV(Y83F) 45.3 96 
∆IV+IV(R82A) 45.7 87    
∆IV+IV(Y83A) 44.3 93 ∆IV+IV(R84E) 43.2 68 
∆IV+IV(R84A) 43.3 74 ∆IV+IV(R84K) 46.2 98 
∆IV+IV(L85A) 45.2 99    
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on the region 41-53 of subunit IV to simple methyl groups has little effect on the 
interaction between subunit IV and the core complex.  As expected, the complex with 
either IV(77-85)A, or IV(81-84)A have significantly lower Tm and ∆H value, when those 
critical residues were changed to alanine.   
All single alanine mutants, except IV(T77A), more or less affect DSC parameters.  
Complex reconstituted with mutant IV(R84A) has a Tm of 43.3 °C, which is the lowest 
among all the single alanine mutants.  This result is consistent with the incorporation test 
(see Fig 9), and it indicates that the mutation R84A has the most impact on the 
incorporation.  The mutant IV(Y81A) shows no significant difference from the wild-type 
subunit IV in the incorporation test (see Fig. 9), but it lowers the complex’s Tm by 1.6 °C 
upon comparison with wild-type subunit IV.  The difference in Tm suggests that the 
alanine mutation at Y81 does affect the interaction between subunit IV and core complex, 
although the IV(Y81A) is still able to strongly bind to the core complex as the wild-type 
IV.  
Significance of Ionic Property of R82 and R84  
When the positively charged side-chain on R82 or R84 is replaced with the neutral 
methyl side-chain, the subunit IV mutant loses about 20% of the reconstitutive activity 
(Table IV), and has a weaker association with the core complex than wild-type subunit IV 
(Fig. 9).  Therefore, it is reasonable to consider that the positive charge in this proximity 
may be important for the reconstitution of the subunit IV with the core complex. 
To investigate the effect of the positively charged side-chain of arginine 82 and 84, 
subunit IV mutants IV(R82E), IV(R82K), IV(R84E), and IV(R84K) were constructed and 



























FIG. 11. Effect of mutation at R82 and R84 on the association of subunit IV with 
the complex.  Conditions were as same as described on Fig. 9.  Cytochrome bc1 
was reconstituted with none (lane N), wild-type (lane W), mutant IV at R82 (R82A, 
E, K) or mutant IV at R84 (R84A, E, K). Ni-NTA columns were washed with buffer 
containing 0.05% dodecylmaltoside before the elution.  S, protein standard: bovine 
serum albumin (66,200), ovalbumin (45,000), carbonic anhydrase (31,000), soybean 













































FIG12.  DSC thermograms of bc1 complexes with mutants at R82 and R84.  
Experiment conditions were as same as on Fig. 10.  
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charged glutamic acid, the reconstitutive activity drops to 56% of the reconstitutive 
activity of the wild-type subunit IV.  When arginine 82 is changed to another positively 
charged residue, lysine, the reconstitutive activity increases to 95%.  Similar effects are 
also observed when mutating arginine 84; the glutamic acid mutant drops the 
reconstitutive activity to 55%, and the lysine mutant increases the reconstitutive activity 
to 100%.  These results reveal the significance of the positive charge on both arginine 82 
and arginine 84. 
To determine their binding affinity to the core complex, the subunit IV mutants 
R82A, R82E, R82K, R84A, R84E, and R84K were reconstituted with the His-tagged 3-
subunit complex and applied to Ni-NTA columns as described above.  Fig. 11 shows 
SDS-PAGE patterns of reconstituted proteins eluted from Ni-NTA columns after washing 
with buffer containing 0.05% DM.  The amounts of both IV(R82K) and IV(R84K) shown 
on the gel are comparable to that of the wild-type subunit IV.  This confirms the 
significance of the positively charged group of these two residues for the interaction 
between subunit IV and the core complex.  However, IV(R82E) and IV(R84E), 
surprisingly show slightly stronger binding to the core complex than IV(R82A) and 
IV(R84A) do, as shown in Fig. 11.  Since the mutation of arginine 82 or 84 to glutamic 
acid has a more drastic effect on the reconstitutive activity of the subunit IV than the 
mutation to alanine, it remains unclear why they would have a better association with the 
3-subunit core complex. 
  Fig. 12 shows the DSC thermograms of the bc1 complex reconstituted with the 
subunit IV mutants at R82 and R84.  When R82 or R84 of the subunit IV is mutated to 
lysine, the thermogram of the reconstituted complex is comparable to the complex 
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reconstituted with the wild-type subunit IV.  However, the thermogram of the complex 
with either IV(R82A), IV(R82E), IV(R84A), or IV(R84E) show significant differences 
from the complex with the wild-type subunit IV.  Conclusively, the positive charge of 
arginine at both 82 and 84 are significant for the function of the subunit IV in interacting 
with the core complex. 
Function of W79, Y81, and Y83  
  Although the mutant IV(W79A) has the same reconstitutive activity as the wild-type 
subunit IV, this mutation significantly decreases the binding affinity of the subunit IV to 
the core complex (see Fig. 9-C) and lowers the Tm of the complex as seen in DSC 
analysis (see Table V).  To study the function of this tryptophan, two mutants, IV(W79Y) 
and IV(W79F) were constructed and characterized.  As shown in Table V and Fig. 13, a 
tyrosine at position 79 is comparable to the tryptophan, and a phenylalanine is better than 
an alanine but not as good as a tryptophan or tyrosine.  Apparently, the aromatic side 
chain is essential for the function of W79.  
For the residues tyrosine 81, neither threonine nor phenylalanine is comparable to the 
tyrosine (see Table IV and Table V), suggesting that both the aromatic ring and the 
hydroxyl group of Y81 are required for its proper function. 
Similar results were observed when the tyrosine 83 was replaced with threonine or 
phenylalanine, indicating the significance of both the aromatic ring and the hydroxyl 
group of the Y83.  However, the mutant IV(Y83F) has 87% of reconstitutive activity, 
which is slightly higher than 80% of the IV(Y83A) and significantly higher than 66% of 
the IV(Y83T) (see Table IV).  In addition, the association test (Fig. 14-A) shows that the 
IV(Y83F) binds the 3-subunit complex stronger than the IV(Y83A) and the IV(Y83T); 
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the DSC analysis (Fig.14-B) also shows that the complex with the IV(Y83F) has higher 
melting temperature than the complexes with the other two subunit IV mutants.  
Conclusively, although neither phenylalanine nor threonine can replace the function of 
the tyrosine at position 83 of the subunit IV, the aromatic ring of the tyrosine 83 
















































FIG. 13. Effect of mutation at the W79 on (A) the association of subunit IV with 
the complex and (B) DSC thermograms.  Conditions are as same as described on 



























































FIG. 14.  Effect of mutation at the Y83 on (A) the association of subunit IV with 
the complex and (B) DSC thermograms.  Experiment conditions are as same as 








SUBUNIT IV REDUCES THE ELECTRON LEAKAGE FROM RHODOBACTER 




The enzymatic activity of the purified three-subunit bc1 complex is only about 25% of 
that of the 4-subunit one.  Several regions and individual amino acid residues on subunit 
IV were identified to be essential for the interaction between the subunit IV and the 3-
subunit core complex in the previous chapters.  However, how the subunit IV affects the 
activity of bc1 complex is still not clear.   
It is reported that during the electron transfer through the mitochondrial bc1 complex, 
a small amount of superoxide anion is generated due to the electron leakage.  Thus the 
amount of superoxide generated by the bc1 complex should be correlated to how well the 
protein is able to prevent electron leaking.  On the other hand, the loss of electrons may 
decrease the enzymatic activity of the bc1 complex.  It is possible that the bc1 complex 
with supernumerary subunits has better control on the electron leakage and therefore has 
higher activity.  
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In this chapter, evidences of the role of subunit IV in preventing electrons from 
leaking out in the R. sphaeroides cytochrome bc1 complex are presented and discussed.   
 
Results and Discussion 
 
Effect of Subunit IV on Reduction of Cytochrome b and Cytochrome c1 by Ubiquinol 
To study the role of subunit IV in the reduction of the bc1 complex by ubiquinol, 
either oxidized 3-subunit complex or 4-subunit complex was mixed with reduced 
ubiquinol in a stopped-flow mixer to examine the pre-steady-state reduction of the 
enzyme with ubiquinol.  Since the concentration of ubiquinol (25 µM) is much higher 
than the concentration of the bc1 complex (3 µM) in the reaction mixture, the 
concentration of the ubiquinol can be considered a constant during the reaction.  This 
allows the reaction to be analyzed as a first-order reaction.  Figure 15-A, B, and C show 
the 1-sec time course of the reduction of cytochrome b, in the absence of inhibitor, in the 
presence of a Qi site inhibitor antimycin A, and Qo site inhibitor myxothiazol 
respectively, while Figure 15-A’, B’ and C’ show the time courses of the reduction of 
cytochrome c1 under the same conditions.   
In Figure15-A, the reduction of cytochrome b is a “tri-phasic” reaction as reported 
with yeast bc1 reduced by menoquinol (86).  Such tri-phasic reaction consists of a rapid 
reduction phase (0-40 msec), a partial re-oxidation phase (40-100 msec), and a slow re-
reduction phase (after 100 msec).  Based on the Q-cycle mechanism, these 3 phases 
represent 1) the reduction of cytochrome b at the Qo site, 2) the oxidation of cytochrome 
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FIG 15. Time course of reduction of cytochrome b and c1 by ubiquinol in 4-
subunit R.s. bc1 complex (solid line) and in 3-subunit complex (dashed 
line) in the absence of inhibitor (A and A’), the presence of antimycin A (B 
and B’) and in the presence of myxothiazol (C and C’). The reactions were 
initiated by mixing equal volume of 50 µM reduced Q0C10Br in 5 mM 
NaH2PO4, 0.01% DM, 0.1% BSA, 1mM KCN, 1mM NaN3, and 6 µM bc1 
complex in 100 mM phosphate buffer, pH 7.4 containing 0.01% DM, 0.1% 
BSA, 1mM KCN and 1mM NaN3 at 23°C in the stopped-flow mixer.  
Antimycin A or myxothiazol was added to 30 µM.  The reduction of 
cytochrome b and c1 was calculated from the wavelength pair of A561nm -A542 nm 
and A551nm - A532 nm respectively, and converted to percentage of reduction by 
using potassium ferric cyanide oxidized spectrum as 0 reduction and sodium 
dithionite reduced spectrum as 100% reduction. All traces here are the average 
of 3 repeated measurements. The numbers indicated beside the curves are the 
estimated rate constants. 
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reduction and oxidation.  However, in Figure 15-A, the subunit IV shows little effect on 
the curves of cytochrome b in the absence of inhibitor; the traces of 3-subunit core 
complex and 4-subunit complex are almost identical.   
Figure 15-A’ displays the time course of cytochrome c1 reduction in the absence of 
inhibitors.  Both traces of 3-subunit and 4-subunit complex can be fitted very well with 
first-order-double-component equations, indicating that the reactions consist of a fast 
phase and a slow phase.  However, the 0.5 sec time-courses are dominated by the fast 
phase, and the slow phase is barely noticed.  For the reduction of cytochrome c1 in the 3-
subunit and 4 subunit complexes, the first-order rate constants of the fast phase are 
estimated as 22.5 and 20.6 s-1 respectively.  While the rate constants do not show 
significant difference between these two traces, the difference lies in the extent of the 
reduction.  At 0.5 sec after mixing, about 40% of cytochrome c1 in the 4-subunit complex 
is reduced, but only 31% of the cytochrome c1 in the 3-subunit complex is reduced.   
Figure 15-B and B’ show the time courses of cytochromes b and c1 reduction by 
ubiquinol in the presence of the Qi site inhibitor antimycin A.  Since the Qi site is 
blocked, reduced cytochrome b is not able to be oxidized at the Qi site.  Therefore, the 
reduction of the cytochrome b no longer shows the ‘tri-phasic” trace as seen in Figure 15-
A.  In the presence of antimycin A, the reductions of both cytochromes b and c1 can be 
fitted with first-order-double-component equations.  The rate constants for the reduction 
of cytochrome b in the 3-subunit and 4 subunit complexes are 20.2 and 23.6 s-1 
respectively; while the rate constants of the reduction of cytochrome c1 are 23.9 and 21.4 
s-1 respectively.  No significant difference is observed between the rate constants of the 3-
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subunit and 4-subunit complexes.  The 4-subunit bc1 complex has significantly more 
cytochrome b and c1 being reduced than the 3-subunit complex after 0.5 sec of reaction.   
Upon treatment of Qo site inhibitor myxothiazol (see Figure 15-C and C’), the 
reductions of cytochrome b are also first-order double-component curves, while the 
cytochrome c1 shows no reduction by ubiquinol in 0.5 sec.   The cytochrome b is believed 
to be reduced by ubiquinol through the Qi site as the Qo site is blocked by the inhibitor 
(86).  The fast phase rate constants of reduction of cytochrome b in 3-subunit complex 
and 4-subunit complex are 75.6 and 62.4 s-1 respectively, suggesting that the electron 
transfer through Qi site is slightly faster in the 3-subunit complex than in the 4-subunit 
complex.   
According to the Q-cycle mechanism, both cytochrome b and cytochrome c1 are 
reduced by ubiquinol through Qo site in either the native or antimycin A treated bc1 
complex.  Surprisingly, little difference can be found between 3-subunit complex and 4-
subunit complex on the rate constants for reduction of cytochromes b or c1 through Qo 
site, suggesting subunit IV does not affect the ubiquinol oxidation at the Qo site.  
However, the difference in the extent of reduction of cytochromes b and c1 shown on 
Figure 15-A’, B, and B’ suggests that the complex without subunit IV is losing significant 
amount of electron during the reaction compared to the 4-subunit complex.   
Figure 16 shows the 50-sec time course of cytochrome b and c1 reduction by 
ubiquinol in the presence of antimycin A.  Cytochromes b of both the 3-subunit complex 
and the 4-subunit complex start getting oxidized at about 5 sec after mixing (see Figure 
16, top panel), indicating that electrons are leaking out from cytochrome b (very likely 
bL).  Meanwhile, cytochromes c1 continue to be slowly reduced and reach about the same 
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FIG 16. Time course of reduction of cytochrome b and c1 by ubiquinol in 4-
subunit R.s. bc1 complex (solid line) and in 3-subunit complex (dashed line) 
in the presence of antimycin A. The reactions were initiated by mixing equal 
volume of 50 µM reduced Q0C10Br in 5 mM NaH2PO4, 0.01% DM, 0.1% BSA, 
1mM KCN, 1mM NaN3, and 6 µM bc1 complex in 100 mM phosphate buffer, 
pH 7.4 containing 0.01% DM, 0.1% BSA, 1mM KCN and 1mM NaN3 at 23°C in 
the stopped-flow mixer.  Antimycin A was added to 30 µM.  The reduction of 
cytochrome b and c1 was calculated from the wavelength pair of A561nm -A542 nm 
and A551nm - A532 nm respectively, and converted to percentage of reduction by 
using potassium ferric cyanide oxidized spectrum as 0 reduction and sodium 
dithionite reduced spectrum as 100% reduction. All traces here are the average of 
3 repeated measurements. The numbers beside curves are estimated rate constants 
of the slow phase. 
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level of reduction for both the 3-subunit and the 4-subunit complexes (see Figure 16, 
bottom panel), indicating that there is no difference between the two complexes in the 
total amount of electron being transferred into the high potential chain (ISP and 
cytochrome c1).  Based on the bifurcated quinol oxidation at the Qo site, there should be 
no difference between the two complexes in the amount of electrons transferred into the 
low potential chain (cytochromes bL and bH).  Apparently, that is not the case.  Figure 16 
clearly demonstrates that the 3-subunit complex loses much more electrons from its 
regular electron-transfer pathway than the 4-subunit complex does.  Therefore, it is 
reasonable to assume that subunit IV is able to decrease the electron leaking from the bc1 
complex.    
Effect of Subunit IV on Superoxide Generation by the bc1 Complex 
To support the hypothesis that subunit IV functions in decreasing electron leakage, 
superoxide generation by bc1 complex was determined.  If the hypothesis is correct, more 
superoxide should be generated from the 3-subunit complex than from the 4-subunit 
complex under the same condition.  Superoxide radicals can be measured by monitoring 
the chemiluminescence produced by the MCLA-superoxide adduct (82,83).   
To measure the generation of superoxide radicals in the pre-steady state reaction of 
the reduction of the bc1 complex by ubiquinol, the stopped-flow assays were set up in the 
same way as the reduction kinetics assays, except that MCLA was added to the quinol 
containing reservoir to a final concentration of 4.0 µM.  Figure 17 shows the 1-sec time 
courses of the superoxide radical generation during reduction of bc1 by ubiquinol in 
absence of any inhibitor (A), in the presence of antimycin A (B) and myxothiazol (C).  
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FIG. 17. Time course of superoxide generation in 4-subunit (solid line) and in 3-
subunit (dashed line) complexes in the absence of inhibitor (A), the presence 
of antimycin A (B) and in the presence of myxothiazol (C). Fifty µM reduced 
Q0C10Br in 5 mM NaH2PO4, 0.01% DM, 0.1% BSA, 1mM KCN, 1mM NaN3 and 
4 µM MCLA were mixed with equal volume of 6 µM bc1 complex in 100 mM 
phosphate buffer, containing 0.01% DM, 0.1% BSA, 1mM KCN, and 1mM NaN3 
at 23°C by a stopped-flow mixer to initiate the reaction.  Antimycin A or 
myxothiazol was added to 30 µM in the bc1 complex sample where needed. The 
superoxide induced MCLA chemiluminescence was detected by the emission 
photomultiplier of the stopped-flow photometer and converted to total production 
of superoxide by using the superoxide generated by xanthine oxidase reaction as a 
standard.  All traces here are the average of 6 repeated measurements.  
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native and antimycin A treated complex, but it has no significant effect on the 
myxothiazol treated complex.  Clearly, this observation supports our hypothesis that 
subunit IV is able to decrease the electron leaking and hence the generation of 
superoxide.  
Effect of Oxygen on the Extent of Cytochrome b Reduction in the bc1 Complex   
The hypothesis is further confirmed by observing the reaction kinetics of antimycin A 
treated complex and ubiquinol under anaerobic conditions.  Figure 18 displays the time 
courses of the reduction of cytochrome b in the cytochrome bc1 complex by ubiquinol 
under either aerobic (A) or anaerobic (B) condition.  Due to the difficulty in obtaining the 
anaerobic condition in the stopped-flow mixer, the results in Figure 18 were done by 
manually mixing the components in an anaerobic cuvette instead of using the stopped-
flow mixer.  Therefore the time zero in Figure 18 is actually about 7-8 sec after mixing.  
Considering the delay, the time courses shown in Figure 18-A is actually the same as 
those done by stopped-flow mixer shown in the top panel of Figure 16.  Therefore, in 
Figure 18-A, the 3-subunit complex shows only 26% of cytochrome b reduced at the 
beginning of the time course while the 4-subunit complex shows 36%; at the end of the 
time courses (80 sec), only 4% of cytochrome b is still reduced in the 3-subunit complex, 
whereas 17% of cytochrome b is reduced in 4-subunit complex.  As discussed previously, 
we assume that the difference is due to the role of subunit IV in decreasing electron 
leaking.   
The anaerobic condition for Figure 18-B was reached by several vacuuming and argon 
flushing cycles before the mixing. Cytochrome c oxidase showed less than 0.5% activity 
under such condition.  Figure 18-B shows that the curves of the two complexes become 
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very similar under the anaerobic condition. In the other words, when oxygen is absent in 
the system, subunit IV effect on the cytochrome b oxidation is not observed any more.   
To establish the relationship between higher superoxide generation and low activity of 
the 3-subunit complex, the activity of the bc1 complex was assayed under anaerobic 
conditions.  If the oxygen is the cause of electron leakage and the low activity of the 3-
subunit complex, the activity should be higher under anaerobic conditions.  However, 
removing oxygen was not able to increase the enzymatic activity of the 3-subunit 
complex.  Therefore, how the electron leakage affects the bc1 complex’s activity is still 












































Figure 18. The effect of oxygen on the reduction of cytochrome b in R.s. bc1 3-
subunit complex (dashed line) and 4-subunit complex (solid line) in the presence 
of antimycin.  The traces show the time courses of reduction of cytochrome b in the 
antimycin A treated complexes in either aerobic (A) or anaerobic (B) condition.  The 
reactions were initiated by mixing 200 µl of 125 µM reduced Q0C10Br from the 
sidearm of an anaerobic cuvett into 900 µl of 3.3 µM bc1 complex in the main chamber 
of the cuvett.  Anaerobic condition was reached by repeatedly evacuating and flushing 
with argon. A560.8nm – A541.6nm was monitored and converted to percentage of 
cytochrome b reduction by using potassium ferric cyanide oxidized sample as 0 
reduction and sodium dithionite reduced sample as 100% reduction.  Due to the delay 
of the manual mixing, the time 0 here actually is about 7-8 second after the mixing. 
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